{"text_format":"3","workbook":"xlsx","n_sheets":68,"sheets":["Cover Page","CONSOLIDATED BALANCE SHEETS","CONSOLIDATED STATEMENTS OF COMP","CONSOLIDATED STATEMENTS OF CASH","CONSOLIDATED BALANCE SHEETS (Pa","Basis of Presentation","Recent Accounting Pronouncement","Revenue from Contracts with Cus","Investments","Inventories","Consumer Loans Receivable","Commercial Loans Receivable","Accrued Expenses and Other Curr","Warranties","Other Liabilities","Debt","Reinsurance and Insurance Loss ","Commitments and Contingencies","Stockholders' Equity and Redeem","Earnings Per Share","Fair Value Measurements","Business Segment Information","Pay vs Performance Disclosure","Insider Trading Arrangements","Basis of Presentation (Policies","Revenue from Contracts with C_2","Investments (Tables)","Inventories (Tables)","Consumer Loans Receivable (Tabl","Commercial Loans Receivables (T","Accrued Expenses and Other Cu_2","Warranties (Tables)","Other Liabilities (Tables)","Reinsurance and Insurance Los_2","Commitments and Contingencies (","Stockholders' Equity and Rede_2","Earnings Per Share (Tables)","Fair Value Measurements (Tables","Business Segment Information (T","Revenue from Contracts with C_3","Investments - Schedule of Inves","Investments - Schedule of Amort","Investments - Schedule of Contr","Investments - Schedule of Recog","Inventories (Details)","Consumer Loans Receivable - Sch","Consumer Loans Receivable - S_2","Consumer Loans Receivable - S_3","Consumer Loans Receivable - S_4","Consumer Loans Receivable - Nar","Commercial Loans Receivable - S","Commercial Loans Receivable -_2","Commercial Loans Receivable - N","Commercial Loans Receivable -_3","Accrued Expenses and Other Cu_3","Warranties (Details)","Other Liabilities (Details)","Debt (Details)","Reinsurance and Insurance Los_3","Reinsurance and Insurance Los_4","Reinsurance and Insurance Los_5","Commitments and Contingencies -","Commitments and Contingencies_2","Stockholders' Equity and Rede_3","Earnings Per Share (Details)","Fair Value Measurements - Sched","Fair Value Measurements - Sch_2","Business Segment Information (D"],"read":"whole","date_system":"1900"}

{"sheet":"Cover Page","index":0,"n_rows":32,"n_cols":3,"rows_kept":32,"merged":[[0,0,1,0]]}
["Cover Page - shares","9 Months Ended"]
[null,"Dec. 28, 2024","Jan. 23, 2025"]
["Cover [Abstract]"," "," "]
["Document Type","10-Q"," "]
["Document Quarterly Report","true"," "]
["Document Period End Date","Dec. 28,  2024"," "]
["Document Transition Report","false"," "]
["Entity File Number","000-08822"," "]
["Entity Registrant Name","CAVCO INDUSTRIES INC."," "]
["Entity Incorporation, State or Country Code","DE"," "]
["Entity Tax Identification Number","56-2405642"," "]
["Entity Address, Address Line One","3636 North Central Ave, Ste 1200"," "]
["Entity Address, City or Town","Phoenix"," "]
["Entity Address, State or Province","AZ"," "]
["Entity Address, Postal Zip Code","85012"," "]
["City Area Code","602"," "]
["Local Phone Number","256-6263"," "]
["Title of 12(b) Security","Common Stock, par value $0.01"," "]
["Trading Symbol","CVCO"," "]
["Security Exchange Name","NASDAQ"," "]
["Entity Current Reporting Status","Yes"," "]
["Entity Interactive Data Current","Yes"," "]
["Entity Filer Category","Large Accelerated Filer"," "]
["Entity Small Business","false"," "]
["Entity Emerging Growth Company","false"," "]
["Entity Shell Company","false"," "]
["Entity Common Stock, Shares Outstanding"," ",{"v":8013148,"d":"8,013,148 "}]
["Entity Central Index Key","0000278166"," "]
["Document Fiscal Year Focus","2025"," "]
["Amendment Flag","false"," "]
["Document Fiscal Period Focus","Q3"," "]
["Current Fiscal Year End Date","--03-29"," "]

{"sheet":"CONSOLIDATED BALANCE SHEETS","index":1,"n_rows":48,"n_cols":3,"rows_kept":48}
["CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Current assets"," "," "]
["Cash and cash equivalents",{"v":362863,"d":"$ 362,863"},{"v":352687,"d":"$ 352,687"}]
["Restricted cash, current",{"v":15178,"d":"15,178 "},{"v":15481,"d":"15,481 "}]
["Accounts receivable, net",{"v":91840,"d":"91,840 "},{"v":77123,"d":"77,123 "}]
["Short-term investments",{"v":16062,"d":"16,062 "},{"v":18270,"d":"18,270 "}]
["Inventories",{"v":243299,"d":"243,299 "},{"v":241339,"d":"241,339 "}]
["Prepaid expenses and other current assets",{"v":79253,"d":"79,253 "},{"v":82870,"d":"82,870 "}]
["Total current assets",{"v":877987,"d":"877,987 "},{"v":851799,"d":"851,799 "}]
["Restricted cash",{"v":585,"d":"585 "},{"v":585,"d":"585 "}]
["Investments",{"v":18287,"d":"18,287 "},{"v":17316,"d":"17,316 "}]
["Property, plant and equipment, net",{"v":226126,"d":"226,126 "},{"v":224199,"d":"224,199 "}]
["Goodwill",{"v":121969,"d":"121,969 "},{"v":121934,"d":"121,934 "}]
["Other intangibles, net",{"v":27068,"d":"27,068 "},{"v":28221,"d":"28,221 "}]
["Operating lease right-of-use assets",{"v":35248,"d":"35,248 "},{"v":39027,"d":"39,027 "}]
["Total assets",{"v":1385767,"d":"1,385,767 "},{"v":1354160,"d":"1,354,160 "}]
["Current liabilities"," "," "]
["Accounts payable",{"v":26088,"d":"26,088 "},{"v":33531,"d":"33,531 "}]
["Accrued expenses and other current liabilities",{"v":259134,"d":"259,134 "},{"v":239736,"d":"239,736 "}]
["Total current liabilities",{"v":285222,"d":"285,222 "},{"v":273267,"d":"273,267 "}]
["Operating lease liabilities",{"v":31472,"d":"31,472 "},{"v":35148,"d":"35,148 "}]
["Other liabilities",{"v":7206,"d":"7,206 "},{"v":7759,"d":"7,759 "}]
["Deferred income taxes",{"v":4642,"d":"4,642 "},{"v":4575,"d":"4,575 "}]
["Stockholders' equity"," "," "]
["Preferred stock, $0.01 par value; 1,000,000 shares authorized; No shares issued or outstanding",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Common stock, $0.01 par value; 40,000,000 shares authorized; Issued 9,422,969 and 9,389,953 shares, respectively; Outstanding 8,066,549 and 8,320,718 shares, respectively",{"v":94,"d":"94 "},{"v":94,"d":"94 "}]
["Treasury stock, at cost; 1,356,420 and 1,069,235 shares, respectively",{"v":-391128,"d":"(391,128)"},{"v":-274693,"d":"(274,693)"}]
["Additional paid-in capital",{"v":286573,"d":"286,573 "},{"v":281216,"d":"281,216 "}]
["Retained earnings",{"v":1161833,"d":"1,161,833 "},{"v":1027127,"d":"1,027,127 "}]
["Accumulated other comprehensive loss",{"v":-147,"d":"(147)"},{"v":-333,"d":"(333)"}]
["Total stockholders' equity",{"v":1057225,"d":"1,057,225 "},{"v":1033411,"d":"1,033,411 "}]
["Total liabilities and stockholders' equity",{"v":1385767,"d":"1,385,767 "},{"v":1354160,"d":"1,354,160 "}]
["Consumer Loans Receivable"," "," "]
["Current assets"," "," "]
["Current portion of loans receivable, net",{"v":33242,"d":"33,242 "},{"v":20713,"d":"20,713 "}]
["Loans receivable, net",{"v":20394,"d":"20,394 "},{"v":23354,"d":"23,354 "}]
["Commercial Loans Receivable"," "," "]
["Current assets"," "," "]
["Current portion of loans receivable, net",{"v":36250,"d":"36,250 "},{"v":43316,"d":"43,316 "}]
["Loans receivable, net",{"v":58103,"d":"58,103 "},{"v":47725,"d":"47,725 "}]
["Commercial Loans Receivable | Nonrelated Party"," "," "]
["Current assets"," "," "]
["Current portion of loans receivable, net",{"v":34892,"d":"34,892 "},{"v":40787,"d":"40,787 "}]
["Loans receivable, net",{"v":51305,"d":"51,305 "},{"v":45660,"d":"45,660 "}]
["Commercial Loans Receivable | Related Party"," "," "]
["Current assets"," "," "]
["Current portion of loans receivable, net",{"v":1358,"d":"1,358 "},{"v":2529,"d":"2,529 "}]
["Loans receivable, net",{"v":6798,"d":"$ 6,798"},{"v":2065,"d":"$ 2,065"}]

{"sheet":"CONSOLIDATED STATEMENTS OF COMP","index":2,"n_rows":31,"n_cols":5,"rows_kept":31,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Income Statement [Abstract]"," "," "," "," "]
["Net revenue",{"v":522040,"d":"$ 522,040"},{"v":446769,"d":"$ 446,769"},{"v":1507100,"d":"$ 1,507,100"},{"v":1374674,"d":"$ 1,374,674"}]
["Cost of sales",{"v":392090,"d":"392,090 "},{"v":343718,"d":"343,718 "},{"v":1157626,"d":"1,157,626 "},{"v":1046787,"d":"1,046,787 "}]
["Gross profit",{"v":129950,"d":"129,950 "},{"v":103051,"d":"103,051 "},{"v":349474,"d":"349,474 "},{"v":327887,"d":"327,887 "}]
["Selling, general and administrative expenses",{"v":65980,"d":"65,980 "},{"v":63312,"d":"63,312 "},{"v":197828,"d":"197,828 "},{"v":186498,"d":"186,498 "}]
["Income from operations",{"v":63970,"d":"63,970 "},{"v":39739,"d":"39,739 "},{"v":151646,"d":"151,646 "},{"v":141389,"d":"141,389 "}]
["Interest income",{"v":5353,"d":"5,353 "},{"v":5234,"d":"5,234 "},{"v":16556,"d":"16,556 "},{"v":15664,"d":"15,664 "}]
["Interest expense",{"v":-155,"d":"(155)"},{"v":-842,"d":"(842)"},{"v":-370,"d":"(370)"},{"v":-1365,"d":"(1,365)"}]
["Other income (expense), net",{"v":168,"d":"168 "},{"v":-224,"d":"(224)"},{"v":315,"d":"315 "},{"v":557,"d":"557 "}]
["Income before income taxes",{"v":69336,"d":"69,336 "},{"v":43907,"d":"43,907 "},{"v":168147,"d":"168,147 "},{"v":156245,"d":"156,245 "}]
["Income tax expense",{"v":-12874,"d":"(12,874)"},{"v":-7920,"d":"(7,920)"},{"v":-33441,"d":"(33,441)"},{"v":-32274,"d":"(32,274)"}]
["Net income",{"v":56462,"d":"56,462 "},{"v":35987,"d":"35,987 "},{"v":134706,"d":"134,706 "},{"v":123971,"d":"123,971 "}]
["Less: net income attributable to redeemable noncontrolling interest",{"v":0,"d":"0 "},{"v":0,"d":"0 "},{"v":0,"d":"0 "},{"v":88,"d":"88 "}]
["Net income attributable to Cavco common stockholders",{"v":56462,"d":"56,462 "},{"v":35987,"d":"35,987 "},{"v":134706,"d":"134,706 "},{"v":123883,"d":"123,883 "}]
["Comprehensive income"," "," "," "," "]
["Net income",{"v":56462,"d":"56,462 "},{"v":35987,"d":"35,987 "},{"v":134706,"d":"134,706 "},{"v":123971,"d":"123,971 "}]
["Reclassification adjustment for securities sold",{"v":-97,"d":"(97)"},{"v":293,"d":"293 "},{"v":174,"d":"174 "},{"v":299,"d":"299 "}]
["Applicable income tax benefit (expense)",{"v":20,"d":"20 "},{"v":-62,"d":"(62)"},{"v":-37,"d":"(37)"},{"v":-63,"d":"(63)"}]
["Net change in unrealized position of investments held",{"v":8,"d":"8 "},{"v":13,"d":"13 "},{"v":62,"d":"62 "},{"v":22,"d":"22 "}]
["Applicable income tax benefit (expense)",{"v":-2,"d":"(2)"},{"v":-3,"d":"(3)"},{"v":-13,"d":"(13)"},{"v":-5,"d":"(5)"}]
["Comprehensive income",{"v":56391,"d":"56,391 "},{"v":36228,"d":"36,228 "},{"v":134892,"d":"134,892 "},{"v":124224,"d":"124,224 "}]
["Less: comprehensive income attributable to redeemable noncontrolling interest",{"v":0,"d":"0 "},{"v":0,"d":"0 "},{"v":0,"d":"0 "},{"v":88,"d":"88 "}]
["Comprehensive income attributable to Cavco common stockholders",{"v":56391,"d":"$ 56,391"},{"v":36228,"d":"$ 36,228"},{"v":134892,"d":"$ 134,892"},{"v":124136,"d":"$ 124,136"}]
["Net income per share attributable to Cavco common stockholders"," "," "," "," "]
["Basic (in usd per share)",{"v":6.97,"d":"$ 6.97"},{"v":4.31,"d":"$ 4.31"},{"v":16.42,"d":"$ 16.42"},{"v":14.47,"d":"$ 14.47"}]
["Diluted (in usd per share)",{"v":6.9,"d":"$ 6.90"},{"v":4.27,"d":"$ 4.27"},{"v":16.25,"d":"$ 16.25"},{"v":14.34,"d":"$ 14.34"}]
["Weighted average shares outstanding"," "," "," "," "]
["Basic (in shares)",{"v":8096538,"d":"8,096,538 "},{"v":8358389,"d":"8,358,389 "},{"v":8203448,"d":"8,203,448 "},{"v":8561209,"d":"8,561,209 "}]
["Diluted (in shares)",{"v":8186814,"d":"8,186,814 "},{"v":8432471,"d":"8,432,471 "},{"v":8291647,"d":"8,291,647 "},{"v":8640288,"d":"8,640,288 "}]

{"sheet":"CONSOLIDATED STATEMENTS OF CASH","index":3,"n_rows":49,"n_cols":3,"rows_kept":49,"merged":[[0,0,1,0],[0,1,0,2]]}
["CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands","9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023"]
["OPERATING ACTIVITIES"," "," "]
["Net income",{"v":134706,"d":"$ 134,706"},{"v":123971,"d":"$ 123,971"}]
["Adjustments to reconcile net income to net cash provided by operating activities"," "," "]
["Depreciation and amortization",{"v":14304,"d":"14,304 "},{"v":13854,"d":"13,854 "}]
["Provision for credit losses",{"v":-874,"d":"(874)"},{"v":-121,"d":"(121)"}]
["Deferred income taxes",{"v":17,"d":"17 "},{"v":-1861,"d":"(1,861)"}]
["Stock-based compensation expense",{"v":6653,"d":"6,653 "},{"v":4698,"d":"4,698 "}]
["Non-cash interest income, net",{"v":-787,"d":"(787)"},{"v":-1230,"d":"(1,230)"}]
["(Gain) loss on sale or retirement of property, plant and equipment, net",{"v":-19,"d":"(19)"},{"v":186,"d":"186 "}]
["Gain on investments and sale of loans, net",{"v":-1901,"d":"(1,901)"},{"v":-5958,"d":"(5,958)"}]
["Changes in operating assets and liabilities, net of acquisitions"," "," "]
["Accounts receivable",{"v":-14762,"d":"(14,762)"},{"v":18161,"d":"18,161 "}]
["Proceeds from sales of consumer loans receivable",{"v":4408,"d":"4,408 "},{"v":81752,"d":"81,752 "}]
["Inventories",{"v":-1960,"d":"(1,960)"},{"v":51182,"d":"51,182 "}]
["Prepaid expenses and other current assets",{"v":4997,"d":"4,997 "},{"v":9909,"d":"9,909 "}]
["Accounts payable, accrued expenses and other liabilities",{"v":9141,"d":"9,141 "},{"v":-23695,"d":"(23,695)"}]
["Net cash provided by operating activities",{"v":139851,"d":"139,851 "},{"v":206104,"d":"206,104 "}]
["INVESTING ACTIVITIES"," "," "]
["Purchases of property, plant and equipment",{"v":-15288,"d":"(15,288)"},{"v":-13237,"d":"(13,237)"}]
["Payments for acquisitions, net",{"v":0,"d":"0 "},{"v":-19702,"d":"(19,702)"}]
["Proceeds from sale of property, plant and equipment",{"v":194,"d":"194 "},{"v":4514,"d":"4,514 "}]
["Purchases of investments",{"v":-21588,"d":"(21,588)"},{"v":-7408,"d":"(7,408)"}]
["Proceeds from sale of investments",{"v":22706,"d":"22,706 "},{"v":9290,"d":"9,290 "}]
["Net cash used in investing activities",{"v":-13976,"d":"(13,976)"},{"v":-26543,"d":"(26,543)"}]
["FINANCING ACTIVITIES"," "," "]
["Payments for taxes on stock option exercises and releases of equity awards",{"v":-3425,"d":"(3,425)"},{"v":-1898,"d":"(1,898)"}]
["Proceeds from exercise of stock options",{"v":2130,"d":"2,130 "},{"v":3098,"d":"3,098 "}]
["Payments on finance leases and other secured financings",{"v":-261,"d":"(261)"},{"v":-442,"d":"(442)"}]
["Payments for common stock repurchases",{"v":-114446,"d":"(114,446)"},{"v":-96781,"d":"(96,781)"}]
["Distributions to noncontrolling interest",{"v":0,"d":"0 "},{"v":-420,"d":"(420)"}]
["Net cash used in financing activities",{"v":-116002,"d":"(116,002)"},{"v":-96443,"d":"(96,443)"}]
["Net increase in cash, cash equivalents and restricted cash",{"v":9873,"d":"9,873 "},{"v":83118,"d":"83,118 "}]
["Cash, cash equivalents and restricted cash at beginning of the fiscal year",{"v":368753,"d":"368,753 "},{"v":283490,"d":"283,490 "}]
["Cash, cash equivalents and restricted cash at end of the period",{"v":378626,"d":"378,626 "},{"v":366608,"d":"366,608 "}]
["Supplemental disclosures of cash flow information"," "," "]
["Cash paid for income taxes",{"v":34173,"d":"34,173 "},{"v":28776,"d":"28,776 "}]
["Cash paid for interest",{"v":30,"d":"30 "},{"v":612,"d":"612 "}]
["Supplemental disclosures of noncash activity"," "," "]
["Change in GNMA loans eligible for repurchase",{"v":730,"d":"730 "},{"v":-3812,"d":"(3,812)"}]
["Consumer Loans Receivable"," "," "]
["Changes in operating assets and liabilities, net of acquisitions"," "," "]
["Loans receivable originated",{"v":-54155,"d":"(54,155)"},{"v":-74306,"d":"(74,306)"}]
["Principal payments received on loans receivable",{"v":42618,"d":"42,618 "},{"v":5480,"d":"5,480 "}]
["Commercial Loans Receivable"," "," "]
["Changes in operating assets and liabilities, net of acquisitions"," "," "]
["Loans receivable originated",{"v":-87543,"d":"(87,543)"},{"v":-83509,"d":"(83,509)"}]
["Principal payments received on loans receivable",{"v":85008,"d":"$ 85,008"},{"v":87591,"d":"$ 87,591"}]

{"sheet":"CONSOLIDATED BALANCE SHEETS (Pa","index":4,"n_rows":11,"n_cols":3,"rows_kept":11}
["CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares","Dec. 28, 2024","Mar. 30, 2024"]
["Statement of Financial Position [Abstract]"," "," "]
["Preferred stock, par value (in usd per share)",{"v":0.01,"d":"$ 0.01"},{"v":0.01,"d":"$ 0.01"}]
["Preferred stock, shares authorized (in shares)",{"v":1000000,"d":"1,000,000 "},{"v":1000000,"d":"1,000,000 "}]
["Preferred stock, shares issued (in shares)",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Preferred stock, shares outstanding (in shares)",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Common stock, par value (in usd per share)",{"v":0.01,"d":"$ 0.01"},{"v":0.01,"d":"$ 0.01"}]
["Common stock, shares authorized (in shares)",{"v":40000000,"d":"40,000,000 "},{"v":40000000,"d":"40,000,000 "}]
["Common stock, shares issued (in shares)",{"v":9422969,"d":"9,422,969 "},{"v":9389953,"d":"9,389,953 "}]
["Common stock, shares outstanding (in shares)",{"v":8066549,"d":"8,066,549 "},{"v":8320718,"d":"8,320,718 "}]
["Treasury stock, common shares (in shares)",{"v":1356420,"d":"1,356,420 "},{"v":1069235,"d":"1,069,235 "}]

{"sheet":"Basis of Presentation","index":5,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Basis of Presentation","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Basis of Presentation","Basis of Presentation The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, \"we,\" \"us,\" \"our,\" the \"Company\" or \"Cavco\") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the \"SEC\") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (\"GAAP\") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered \"Notes\" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated. In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2024 Annual Report on Form 10-K for the year ended March 30, 2024, filed with the SEC (\"Form 10-K\"). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the Consolidated Financial Statements. The Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows for the interim periods are not necessarily indicative of the results or cash flows for the full year. The Company operates on a 52-53 week fiscal year ending on the Saturday nearest to March 31 st of each year. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest March 31 st . The current fiscal year will end on March 29, 2025 and will include 52 weeks. For a description of significant accounting policies used in the preparation of our Consolidated Financial Statements, please refer to Note 1 of the Notes to Consolidated Financial Statements included in the Form 10-K."]

{"sheet":"Recent Accounting Pronouncement","index":6,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Recent Accounting Pronouncements","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Accounting Policies [Abstract]"," "]
["Recent Accounting Pronouncements","Recent Accounting Pronouncements The Company considers the applicability and impact of all Accounting Standards Updates (\"ASUs\") issued by the Financial Accounting Standards Board (\"FASB\"). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires companies to enhance the disclosures about segment expenses. The new standard requires the identification and disclosure of the Company’s Chief Operating Decision Maker (\"CODM\"), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (\"ASU 2024-03\"), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (\"ASU 2025-01\"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements."]

{"sheet":"Revenue from Contracts with Cus","index":7,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Revenue from Contracts with Customers","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Revenue from Contract with Customer [Abstract]"," "]
["Revenue from Contracts with Customers","Revenue from Contracts with Customers The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, December 30, Factory-built housing Home sales $ 471,998 $ 400,633 $ 1,378,103 $ 1,250,417 Delivery, setup and other revenues 28,862 26,306 67,148 67,697 500,860 426,939 1,445,251 1,318,114 Financial services Insurance agency commissions received from third-party insurance companies 1,246 1,229 3,920 3,145 All other sources 19,934 18,601 57,929 53,415 21,180 19,830 61,849 56,560 $ 522,040 $ 446,769 $ 1,507,100 $ 1,374,674 "]

{"sheet":"Investments","index":8,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Investments","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Investments, Debt and Equity Securities [Abstract]"," "]
["Investments","Investments Investments consisted of the following (in thousands): December 28, March 30, Available-for-sale debt securities $ 21,783 $ 18,669 Marketable equity securities 7,434 11,961 Non-marketable equity investments 5,132 4,956 34,349 35,586 Less short-term investments (16,062) (18,270) $ 18,287 $ 17,316 The amortized cost and fair value of our investments in available-for-sale debt securities, by security type, are shown in the table below (in thousands): December 28, 2024 March 30, 2024 Amortized Fair Amortized Cost Fair Residential mortgage-backed securities $ 4,146 $ 4,093 $ 2,933 $ 2,865 State and political subdivision debt securities 6,565 6,515 5,041 4,930 Corporate debt securities 11,257 11,175 11,117 10,874 $ 21,968 $ 21,783 $ 19,091 $ 18,669 The amortized cost and fair value of our investments in available-for-sale debt securities, by contractual maturity, are shown in the table below (in thousands). Expected maturities may differ from contractual maturities as borrowers at times have the right to call or prepay obligations, with or without penalties. December 28, 2024 Amortized Fair Due in less than one year $ 8,402 $ 8,332 Due after one year through five years 7,088 7,047 Due after five years through ten years 2,332 2,311 Mortgage-backed securities 4,146 4,093 $ 21,968 $ 21,783 Net investment gains and losses on marketable equity securities were as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Marketable equity securities Net gain (loss) recognized during the period $ (954) $ 776 $ (440) $ 1,051 Less: Net (gain) recognized on securities sold during the period (1,649) (235) (1,561) (365) Unrealized gain (loss) recognized during the period on securities still held $ (2,603) $ 541 $ (2,001) $ 686 "]

{"sheet":"Inventories","index":9,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Inventories","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Inventory Disclosure [Abstract]"," "]
["Inventories","Inventories Inventories consisted of the following (in thousands): December 28, March 30, Raw materials $ 78,631 $ 78,241 Work in process 30,027 27,977 Finished goods 134,641 135,121 $ 243,299 $ 241,339 "]

{"sheet":"Consumer Loans Receivable","index":10,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Consumer Loans Receivable","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Receivables [Abstract]"," "]
["Consumer Loans Receivable","Consumer Loans Receivable The following table summarizes consumer loans receivable (in thousands): December 28, March 30, Loans held for investment, previously securitized $ 14,476 $ 16,968 Loans held for investment 11,898 12,826 Loans held for sale 23,233 15,140 Construction advances 6,042 722 55,649 45,656 Deferred financing fees and other, net (1,088) (523) Allowance for loan losses (925) (1,066) 53,636 44,067 Less current portion (33,242) (20,713) $ 20,394 $ 23,354 The consumer loans held for investment had the following characteristics: December 28, March 30, Weighted average contractual interest rate 8.1 % 8.1 % Weighted average effective interest rate 8.1 % 10.4 % Weighted average months to maturity 210 196 The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands): December 28, March 30, Current $ 53,709 $ 43,810 31 to 60 days 996 1,063 61 to 90 days 373 131 91+ days 571 652 $ 55,649 $ 45,656 The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Prior Total Prime- FICO score 680 and greater $ 15,726 $ 9,225 $ 324 $ 93 $ 766 $ 13,859 $ 39,993 Near Prime- FICO score 620-679 2,426 1,325 — — 1,033 8,874 13,658 Sub-Prime- FICO score less than 620 310 — — — 17 695 1,022 No FICO score 252 443 — — — 281 976 $ 18,714 $ 10,993 $ 324 $ 93 $ 1,816 $ 23,709 $ 55,649 March 30, 2024 2024 2023 2022 2021 2020 Prior Total Prime- FICO score 680 and greater $ 14,107 $ 328 $ 96 $ 885 $ 1,808 $ 14,425 $ 31,649 Near Prime- FICO score 620-679 1,633 — — 1,202 942 8,684 12,461 Sub-Prime- FICO score less than 620 — — — 18 49 723 790 No FICO score 447 — — — — 309 756 $ 16,187 $ 328 $ 96 $ 2,105 $ 2,799 $ 24,141 $ 45,656 As of December 28, 2024, 55% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas. As of March 30, 2024, 46% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas and 10% was concentrated in Florida. Other than Texas and Florida, no sta te had concentrations in excess of 10% of the outstanding principal balance of the consumer loans receivable as of December 28, 2024 or March 30, 2024. The commercial loans receivable balance consists of direct financing arrangements for the home product needs of our independent distributors, community owners and developers. Commercial loans receivable, net consisted of the following (in thousands): December 28, March 30, Loans receivable $ 94,902 $ 91,938 Allowance for loan losses (335) (781) Deferred financing fees, net (214) (116) 94,353 91,041 Less current portion of commercial loans receivable (including from affiliates), net (36,250) (43,316) $ 58,103 $ 47,725 The commercial loans receivable balance had the following characteristics: December 28, March 30, Weighted average contractual interest rate 7.7 % 7.4 % Weighted average months outstanding 10 12 Nonperforming status includes loans accounted for on a non-accrual basis and accruing loans with principal payments 90 days or more past due. As of December 28, 2024 and March 30, 2024, there were no commercial loans considered nonperforming. The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Total Performing $ 54,916 $ 27,832 $ 8,734 $ 1,466 $ 1,954 $ 94,902 March 30, 2024 2024 2023 2022 2021 2020 Total Performing $ 57,691 $ 25,066 $ 4,823 $ 2,144 $ 2,214 $ 91,938 As of December 28, 2024 and March 30, 2024, there were no commercial loans 90 days or more past due that were still accruing interest, and we were not aware of any potential problem loans that would have a material effect on the commercial loans receivable balance. As of December 28, 2024, we had concentrations of our outstanding principal balance of the commercial loans receivable balance in New York of 18% and California of 16%. As of March 30, 2024, 18% of our outstanding principal balance of the commercial loans receivable balance was in New York. No other state had concentrations in excess of 10% of the outstanding principal balance of the commercial loans receivable as of December 28, 2024 or March 30, 2024. As of December 28, 2024 and March 30, 2024, one independent third-party and its affiliates comprised 10% and 13%, respectively, of the net commercial loans receivable principal balance outstanding, all of which are secured."]

{"sheet":"Commercial Loans Receivable","index":11,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Commercial Loans Receivable","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Receivables [Abstract]"," "]
["Commercial Loans Receivable","Consumer Loans Receivable The following table summarizes consumer loans receivable (in thousands): December 28, March 30, Loans held for investment, previously securitized $ 14,476 $ 16,968 Loans held for investment 11,898 12,826 Loans held for sale 23,233 15,140 Construction advances 6,042 722 55,649 45,656 Deferred financing fees and other, net (1,088) (523) Allowance for loan losses (925) (1,066) 53,636 44,067 Less current portion (33,242) (20,713) $ 20,394 $ 23,354 The consumer loans held for investment had the following characteristics: December 28, March 30, Weighted average contractual interest rate 8.1 % 8.1 % Weighted average effective interest rate 8.1 % 10.4 % Weighted average months to maturity 210 196 The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands): December 28, March 30, Current $ 53,709 $ 43,810 31 to 60 days 996 1,063 61 to 90 days 373 131 91+ days 571 652 $ 55,649 $ 45,656 The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Prior Total Prime- FICO score 680 and greater $ 15,726 $ 9,225 $ 324 $ 93 $ 766 $ 13,859 $ 39,993 Near Prime- FICO score 620-679 2,426 1,325 — — 1,033 8,874 13,658 Sub-Prime- FICO score less than 620 310 — — — 17 695 1,022 No FICO score 252 443 — — — 281 976 $ 18,714 $ 10,993 $ 324 $ 93 $ 1,816 $ 23,709 $ 55,649 March 30, 2024 2024 2023 2022 2021 2020 Prior Total Prime- FICO score 680 and greater $ 14,107 $ 328 $ 96 $ 885 $ 1,808 $ 14,425 $ 31,649 Near Prime- FICO score 620-679 1,633 — — 1,202 942 8,684 12,461 Sub-Prime- FICO score less than 620 — — — 18 49 723 790 No FICO score 447 — — — — 309 756 $ 16,187 $ 328 $ 96 $ 2,105 $ 2,799 $ 24,141 $ 45,656 As of December 28, 2024, 55% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas. As of March 30, 2024, 46% of the outstanding principal balance of the consumer loans receivable portfolio was concentrated in Texas and 10% was concentrated in Florida. Other than Texas and Florida, no sta te had concentrations in excess of 10% of the outstanding principal balance of the consumer loans receivable as of December 28, 2024 or March 30, 2024. The commercial loans receivable balance consists of direct financing arrangements for the home product needs of our independent distributors, community owners and developers. Commercial loans receivable, net consisted of the following (in thousands): December 28, March 30, Loans receivable $ 94,902 $ 91,938 Allowance for loan losses (335) (781) Deferred financing fees, net (214) (116) 94,353 91,041 Less current portion of commercial loans receivable (including from affiliates), net (36,250) (43,316) $ 58,103 $ 47,725 The commercial loans receivable balance had the following characteristics: December 28, March 30, Weighted average contractual interest rate 7.7 % 7.4 % Weighted average months outstanding 10 12 Nonperforming status includes loans accounted for on a non-accrual basis and accruing loans with principal payments 90 days or more past due. As of December 28, 2024 and March 30, 2024, there were no commercial loans considered nonperforming. The following table disaggregates the outstanding principal balance of our commercial loans receivable by fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Total Performing $ 54,916 $ 27,832 $ 8,734 $ 1,466 $ 1,954 $ 94,902 March 30, 2024 2024 2023 2022 2021 2020 Total Performing $ 57,691 $ 25,066 $ 4,823 $ 2,144 $ 2,214 $ 91,938 As of December 28, 2024 and March 30, 2024, there were no commercial loans 90 days or more past due that were still accruing interest, and we were not aware of any potential problem loans that would have a material effect on the commercial loans receivable balance. As of December 28, 2024, we had concentrations of our outstanding principal balance of the commercial loans receivable balance in New York of 18% and California of 16%. As of March 30, 2024, 18% of our outstanding principal balance of the commercial loans receivable balance was in New York. No other state had concentrations in excess of 10% of the outstanding principal balance of the commercial loans receivable as of December 28, 2024 or March 30, 2024. As of December 28, 2024 and March 30, 2024, one independent third-party and its affiliates comprised 10% and 13%, respectively, of the net commercial loans receivable principal balance outstanding, all of which are secured."]

{"sheet":"Accrued Expenses and Other Curr","index":12,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Accrued Expenses and Other Current Liabilities","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Payables and Accruals [Abstract]"," "]
["Accrued Expenses and Other Current Liabilities","Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): December 28, March 30, Salaries, wages and benefits $ 44,338 $ 38,125 Customer deposits 39,795 40,856 Estimated warranties 34,412 31,718 Unearned insurance premiums 33,419 33,449 Accrued volume rebates 30,481 21,167 Insurance loss reserves 12,254 10,540 Accrued insurance 12,226 14,124 Other 52,209 49,757 $ 259,134 $ 239,736 "]

{"sheet":"Warranties","index":13,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Warranties","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Product Warranties Disclosures [Abstract]"," "]
["Warranties","Warranties Activity in the liability for estimated warranties was as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Balance at beginning of period $ 33,081 $ 33,015 $ 31,718 $ 31,368 Charged to costs and expenses 14,322 11,341 40,403 36,956 Payments and deductions (12,991) (11,534) (37,709) (35,502) Balance at end of period $ 34,412 $ 32,822 $ 34,412 $ 32,822 "]

{"sheet":"Other Liabilities","index":14,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Other Liabilities","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Debt Disclosure [Abstract]"," "]
["Other Liabilities","Other Liabilities The following table summarizes secured financings and other obligations (in thousands): December 28, March 30, Finance lease liabilities $ 6,106 $ 6,166 Other secured financing 1,622 1,916 7,728 8,082 Less current portion included in Accrued expenses and other current liabilities (522) (323) $ 7,206 $ 7,759 "]

{"sheet":"Debt","index":15,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Debt","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Debt Disclosure [Abstract]"," "]
["Debt","Debt On November 12, 2024, the Company entered into that certain Amended and Restated Credit Agreement among the Company, Bank of America, N.A., as administrative agent, swing line lender, letter of credit issuer, and the guarantors party thereto (the \"Credit Agreement\"), providing for a $75 million revolving credit facility (the \"Revolving Credit Facility\"), including a $10 million letter of credit sub-facility. The Revolving Credit Facility matures on November 12, 2029. The Credit Agreement amends and restates the previous credit agreement between the parties entered into on November 22, 2022. Loans under the Revolving Credit Facility will bear interest at a rate equal to (i) the Secured Overnight Financing Rate, plus a credit spread adjustment of 0.10% (as adjusted, \"Term SOFR\"), plus the \"applicable rate\" or (ii) the \"base rate\" (defined as the highest of (a) the Bank of America prime rate, (b) the Federal Funds rate plus 0.50%, and (c) Term SOFR plus 1.00%) plus the \"applicable rate.\" The applicable rate will be determined in accordance with a pricing grid based on the Company's Consolidated Total Leverage Ratio (as defined in the Credit Agreement) ranging from 1.25% to 1.50% per annum for Term SOFR rate loans and from 0.25% to 0.50% per annum for base rate loans. In addition, the Company will pay a commitment fee on the unused portion of the Revolving Credit Facility of 0.20% per annum. The Revolving Credit Facility is guaranteed, on a joint and several basis, by certain of the Company's subsidiaries. Subject to certain conditions and requirements set forth in the Credit Agreement, including the availability of additional lender commitments, the Company may request from time to time one or more term loan facilities, or increases in the aggregate commitments under the Revolving Credit Facility, in an aggregate amount not exceeding $75 million. The Credit Agreement contains customary representations and warranties, affirmative and negative covenants (including restrictions, subject to customary exceptions, qualifications, and baskets, on the ability of the Company and its subsidiaries to incur additional indebtedness or guarantees of indebtedness, pay dividends or distributions on, redeem, repurchase, or retire capital stock, make investments, loans, advances, or acquisitions, enter into sale and leaseback transactions, engage in transactions with affiliates, create liens, transfer or sell assets, create restrictions on the payment of dividends or other distributions from subsidiaries, and consolidate, merge, or transfer all or substantially all of the assets of the Company and its subsidiaries taken as a whole), and events of default (as defined in the Credit Agreement). In addition, the Credit Agreement includes the following financial covenants (i) as of the end of any fiscal quarter, the Consolidated Total Leverage Ratio (as defined in the Credit Agreement) cannot exceed 3.25 to 1.00 and (ii) a requirement to maintain Consolidated EBITDA (as defined in the Credit Agreement) for any period of four fiscal quarters of at least $75 million. As of December 28, 2024 and March 30, 2024, there were no borrowings outstanding under the Revolving Credit Facility or the previous credit agreement entered into on November 22, 2022 and we were in compliance with all covenants."]

{"sheet":"Reinsurance and Insurance Loss ","index":16,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Reinsurance and Insurance Loss Reserves","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Insurance [Abstract]"," "]
["Reinsurance and Insurance Loss Reserves","Reinsurance and Insurance Loss Reserves Certain of Standard Casualty Company's premiums and benefits are assumed from and ceded to other insurance companies under various reinsurance agreements. We remain obligated for amounts ceded in the event that the reinsurers do not meet their obligations. The effects of reinsurance on premiums written and earned were as follows (in thousands): Three Months Ended December 28, 2024 December 30, 2023 Written Earned Written Earned Direct premiums $ 19,260 $ 24,645 $ 11,135 $ 10,693 Assumed premiums—nonaffiliated 21,534 20,629 8,430 8,459 Ceded premiums—nonaffiliated (17,387) (17,387) (6,406) (6,406) $ 23,407 $ 27,887 $ 13,159 $ 12,746 Nine Months Ended December 28, 2024 December 30, 2023 Written Earned Written Earned Direct premiums $ 32,763 $ 36,947 $ 31,581 $ 28,740 Assumed premiums—nonaffiliated 33,269 30,133 27,735 25,880 Ceded premiums—nonaffiliated (25,572) (25,572) (18,971) (18,971) $ 40,460 $ 41,508 $ 40,345 $ 35,649 Typical insurance policies written or assumed have a maximum coverage of $0.4 million per claim, of which we cede $0.15 million of the risk of loss per reinsurance. Therefore, our risk of loss is limited to $0.25 million per claim on typical policies, subject to the reinsurers meeting their obligations. After this limit, amounts are recoverable through reinsurance for catastrophic losses in excess of $4.0 million per occurrence, up to a maximum of $110 million in the aggregate for that occurrence. The following details the activity in the incurred but not reported reserve for the three and nine months ended December 28, 2024 a nd December 30, 2023 (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Balance at beginning of period $ 14,620 $ 9,154 $ 10,540 $ 10,939 Net incurred losses during the period 9,662 9,489 41,753 29,152 Net claim payments during the period (12,028) (9,189) (40,039) (30,637) Balance at end of period $ 12,254 $ 9,454 $ 12,254 $ 9,454 "]

{"sheet":"Commitments and Contingencies","index":17,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Commitments and Contingencies","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Commitments and Contingencies Disclosure [Abstract]"," "]
["Commitments and Contingencies","Commitments and Contingencies Repurchase Contingencies . The maximum amount for which the Company was liable under the terms of repurchase agreements with financial institutions that provide inventory financing to independent distributors of our products approximated $122 million and $121 million at December 28, 2024 and March 30, 2024, respectively, without reduction for the estimated resale value of the home s. In the quarter ended December 28, 2024 we received one repurchase demand notice for two homes. In all cases, the estimated fair value exceeded the repurchase price so no loss reserve was deemed necessary. Our reserve for repurchase commitments, re corded in Accrued expenses and other current liabilities, was $3.2 million at December 28, 2024 and $2.9 million at March 30, 2024. Construction-Period Mortgages. Loan contracts with off-balance sheet commitments are summarized below (in thousands): December 28, March 30, Construction loan contract amount $ 12,669 $ 1,960 Cumulative advances (6,042) (722) $ 6,627 $ 1,238 Representations and Warranties of Mortgages Sold . The reserve for contingent repurchases and indemnification obliga tions was $0.7 million as of December 28, 2024 and $0.6 million as of March 30, 2024, included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. There were no claim requests that resulted in the repurchase of any loans during the nine months ended December 28, 2024 or December 30, 2023 . Interest Rate Lock Commitments (\"IRLCs\") . As of December 28, 2024 and March 30, 2024, we had outstanding IRLCs with a notional amount of $10.1 million and $39.0 million, respectively. For the three and nine months ended December 28, 2024, we recognized insignificant non-cash losses and gains, respectively, on outstanding IRLCs. For the three and nine months ended December 30, 2023, we recognized insignificant non-cash gains and losses on outstanding IRLCs. Forward Sales Commitments . As of December 28, 2024 and March 30, 2024, we had $15.0 million and $2.8 million in outstanding forward sales commitments for sales of mortgage backed securities and whole loan commitments (collectively, the \"Commitments\"), respectively. During the three and nine months ended December 28, 2024, we recognized insignificant non-cash gains. During the three and nine months ended December 30, 2023, we recognized insignificant non-cash losses. Legal Matters. We are party to certain lawsuits in the ordinary course of business. Based on management's present knowledge of the facts and (in certain cases) advice of outside counsel, management does not believe that loss contingencies arising from pending matters are likely to have a material adverse effect on our consolidated financial position, liquidity or results of operations after taking into account any existing reserves, which reserves are included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. However, future events or circumstances that may currently be unknown to management will determine whether the resolution of pending or threatened litigation or claims will ultimately have a material effect on our consolidated financial position, liquidity or results of operations in any future reporting periods."]

{"sheet":"Stockholders' Equity and Redeem","index":18,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stockholders' Equity and Redeemable Noncontrolling Interest","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Stockholders' Equity Note [Abstract]"," "]
["Stockholders' Equity and Redeemable Noncontrolling Interest","Stockholders' Equity and Redeemable Noncontrolling Interest The following tables represent changes in stockholders' equity attributable to Cavco's stockholders and redeemable noncontrolling interest during the nine months ended December 28, 2024 and December 30, 2023, respectively (dollars in thousands): Equity Attributable to Cavco Stockholders Treasury stock Additional paid-in capital Retained earnings Accumulated other comprehensive (loss) income Total Common Stock Shares Amount Balance, March 30, 2024 9,389,953 $ 94 $ (274,693) $ 281,216 $ 1,027,127 $ (333) $ 1,033,411 Net income — — — — 34,429 — 34,429 Other comprehensive income, net — — — — — 58 58 Net issuance of common stock under stock incentive plans 11,104 — — (2,348) — — (2,348) Stock-based compensation — — — 2,194 — — 2,194 Common stock repurchases (29,204) (29,204) Balance, June 29, 2024 9,401,057 94 (303,897) 281,062 1,061,556 (275) 1,038,540 Net income — — — — 43,815 — 43,815 Other comprehensive income, net — — — — — 198 198 Net issuance of common stock under stock incentive plans 16,275 — 1,220 — — 1,220 Stock-based compensation — — — 2,713 — — 2,713 Common stock repurchases — — (44,509) — — — (44,509) Balance, September 28, 2024 9,417,332 94 (348,406) 284,995 1,105,371 (77) 1,041,977 Net income — — — — 56,462 — 56,462 Other comprehensive income, net — — — — — (70) (70) Net issuance of common stock under stock incentive plans 5,637 — — (168) — — (168) Stock-based compensation — — — 1,746 — — 1,746 Common stock repurchases — — (42,722) — — — (42,722) Balance, December 28, 2024 9,422,969 $ 94 $ (391,128) $ 286,573 $ 1,161,833 $ (147) $ 1,057,225 Equity Attributable to Cavco Stockholders Treasury stock Additional paid-in capital Retained earnings Accumulated other comprehensive (loss) income Total Redeemable noncontrolling interest Common Stock Shares Amount Balance, April 1, 2023 9,337,125 $ 93 $ (164,452) $ 271,950 $ 869,310 $ (615) $ 976,286 $ 1,219 Net income — — — — 46,357 — 46,357 54 Other comprehensive loss, net — — — — — (42) (42) — Net issuance of common stock under stock incentive plans 10,095 — — (1,213) — — (1,213) — Stock-based compensation — — — 1,438 — — 1,438 — Distributions — — — — — — — (120) Valuation adjustment — — — — — — — (33) Balance, July 1, 2023 9,347,220 93 (164,452) 272,175 915,667 (657) 1,022,826 1,120 Net income — — — — 41,539 — 41,539 34 Other comprehensive income, net — — — — — 54 54 — Net issuance of common stock under stock incentive plans 9,201 1 — 478 — — 479 — Stock-based compensation — — — 1,551 — — 1,551 — Common stock repurchases — — (47,194) — — — (47,194) — Distributions — — — — — — — (180) Conversion to mandatorily redeemable noncontrolling interest — — — — — — — (974) Balance, September 30, 2023 9,356,421 94 (211,646) 274,204 957,206 (603) 1,019,255 — Net income — — — — 35,987 — 35,987 — Other comprehensive income, net — — — — — 241 241 — Net issuance of common stock under stock incentive plans 24,726 — — 1,934 — — 1,934 — Stock-based compensation — — — 1,709 — — 1,709 — Common stock repurchases — — (50,426) — — — (50,426) — Balance, December 30, 2023 9,381,147 $ 94 $ (262,072) $ 277,847 $ 993,193 $ (362) $ 1,008,700 $ — "]

{"sheet":"Earnings Per Share","index":19,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Earnings Per Share","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Earnings Per Share [Abstract]"," "]
["Earnings Per Share","Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (dollars in thousands, except per share amounts): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Net income attributable to Cavco common stockholders $ 56,462 $ 35,987 $ 134,706 $ 123,883 Weighted average shares outstanding Basic 8,096,538 8,358,389 8,203,448 8,561,209 Effect of dilutive securities 90,276 74,082 88,199 79,079 Diluted 8,186,814 8,432,471 8,291,647 8,640,288 Net income per share attributable to Cavco common stockholders Basic $ 6.97 $ 4.31 $ 16.42 $ 14.47 Diluted $ 6.90 $ 4.27 $ 16.25 $ 14.34 Anti-dilutive common stock equivalents excluded — — 169 316 "]

{"sheet":"Fair Value Measurements","index":20,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Fair Value Measurements","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Fair Value Disclosures [Abstract]"," "]
["Fair Value Measurements","Fair Value Measurements The book value and estimated fair value of our financial instruments were as follows (in thousands): December 28, 2024 March 30, 2024 Book Estimated Book Estimated Available-for-sale debt securities $ 21,783 $ 21,783 $ 18,669 $ 18,669 Marketable equity securities 7,434 7,434 11,961 11,961 Non-marketable equity investments 5,132 5,132 4,956 4,956 Consumer loans receivable 53,636 57,114 44,067 49,105 Commercial loans receivable 94,353 79,664 91,041 80,764 Other secured financing (1,622) (1,536) (1,916) (1,841) See Note 20, Fair Value Measurements, and the Fair Value of Financial Instruments caption in Note 1, Summary of Significant Accounting Policies, in the Form 10-K for more information on the methodologies we use in determining fair value. Mortgage Servicing . Mortgage Servicing Rights (\"MSRs\") are recorded at fair value in Prepaid expenses and other current assets on the Consolidated Balance Sheets. December 28, March 30, Number of loans serviced with MSRs 3,693 3,842 Weighted average servicing fee (basis points) 34.80 34.79 Capitalized servicing multiple 186.29 % 188.59 % Capitalized servicing rate (basis points) 64.83 65.61 Serviced portfolio with MSRs (in thousands) $ 458,268 $ 482,898 MSRs (in thousands) $ 2,971 $ 3,168 "]

{"sheet":"Business Segment Information","index":21,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Business Segment Information","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Segment Reporting [Abstract]"," "]
["Business Segment Information","Business Segment Information We operate principally in two segments: (1) factory-built housing, which includes wholesale and retail factory-built housing operations, and (2) financial services, which includes manufactured housing consumer finance and insurance. The following table provides selected financial data by segment (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Net revenue: Factory-built housing $ 500,860 $ 426,939 $ 1,445,251 $ 1,318,114 Financial services 21,180 19,830 61,849 56,560 $ 522,040 $ 446,769 $ 1,507,100 $ 1,374,674 Income (loss) before income taxes: Factory-built housing $ 63,150 $ 42,070 $ 168,155 $ 154,121 Financial services 6,186 1,837 (8) 2,124 $ 69,336 $ 43,907 $ 168,147 $ 156,245 December 28, March 30, Total assets: Factory-built housing $ 1,160,795 $ 1,141,237 Financial services 224,972 212,923 $ 1,385,767 $ 1,354,160 "]

{"sheet":"Pay vs Performance Disclosure","index":22,"n_rows":4,"n_cols":5,"rows_kept":4,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Pay vs Performance Disclosure - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Pay vs Performance Disclosure"," "," "," "," "]
["Net Income (Loss)",{"v":56462,"d":"$ 56,462"},{"v":35987,"d":"$ 35,987"},{"v":134706,"d":"$ 134,706"},{"v":123883,"d":"$ 123,883"}]

{"sheet":"Insider Trading Arrangements","index":23,"n_rows":31,"n_cols":3,"rows_kept":31,"merged":[[0,0,1,0]]}
["Insider Trading Arrangements","3 Months Ended","9 Months Ended"]
[null,"Dec. 28, 2024 shares","Dec. 28, 2024 shares"]
["Trading Arrangements, by Individual"," "," "]
["Non-Rule 10b5-1 Arrangement Adopted","false"," "]
["Non-Rule 10b5-1 Arrangement Terminated","false"," "]
["Julia Sze [Member]"," "," "]
["Trading Arrangements, by Individual"," "," "]
["Material Terms of Trading Arrangement"," ","On December 10, 2024, Julia Sze, a director, terminated her previously adopted plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c). This plan was entered into on August 9, 2024, was set to end on December 10, 2024, and provided for the sale of 250 shares of our Common Stock."]
["Name","Julia Sze"," "]
["Title","director"," "]
["Rule 10b5-1 Arrangement Terminated","true"," "]
["Termination Date","December 10, 2024"," "]
["Aggregate Available",{"v":250,"d":"250 "},{"v":250,"d":"250 "}]
["David Greenblatt [Member]"," "," "]
["Trading Arrangements, by Individual"," "," "]
["Material Terms of Trading Arrangement"," ","On December 4, 2024, David Greenblatt, a director, adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the \"Greenblatt 10b5-1 Plan\"). This plan provides for a first possible trade date of March 5, 2025, and terminates automatically on April 15, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Greenblatt 10b5-1 Plan is up to 4,000 shares of Common Stock."]
["Name","David Greenblatt"," "]
["Title","director"," "]
["Rule 10b5-1 Arrangement Adopted","true"," "]
["Adoption Date","December 4, 2024"," "]
["Arrangement Duration","41 days"," "]
["Aggregate Available",{"v":4000,"d":"4,000 "},{"v":4000,"d":"4,000 "}]
["Seth Schuknecht [Member]"," "," "]
["Trading Arrangements, by Individual"," "," "]
["Material Terms of Trading Arrangement"," ","On December 5, 2024, Seth Schuknecht, Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary also adopted a programmed plan of transactions intended to satisfy the affirmative defense provided by Rule 10b5-1(c) (the \"Schuknecht 10b5-1 Plan\"). This plan provides for a first possible trade date of March 6, 2025, and terminates automatically on October 31, 2025, if not before. The aggregate number of shares to potentially be sold pursuant to the Schuknecht 10b5-1 Plan is up to 167 shares of Common Stock."]
["Name","Seth Schuknecht"," "]
["Title","Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary"," "]
["Rule 10b5-1 Arrangement Adopted","true"," "]
["Adoption Date","On December 5, 2024"," "]
["Arrangement Duration","239 days"," "]
["Aggregate Available",{"v":167,"d":"167 "},{"v":167,"d":"167 "}]

{"sheet":"Basis of Presentation (Policies","index":24,"n_rows":11,"n_cols":2,"rows_kept":11,"merged":[[0,0,1,0]]}
["Basis of Presentation (Policies)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Organization, Consolidation and Presentation of Financial Statements [Abstract]"," "]
["Principles of Consolidation","The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, \"we,\" \"us,\" \"our,\" the \"Company\" or \"Cavco\") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the \"SEC\") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (\"GAAP\") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered \"Notes\" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated. In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2024 Annual Report on Form 10-K for the year ended March 30, 2024, filed with the SEC (\"Form 10-K\")."]
["Accounting Estimate","The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying Notes. Due to uncertainties, actual results could differ from the estimates and assumptions used in preparation of the Consolidated Financial Statements."]
["Fiscal Year","The Consolidated Statements of Comprehensive Income and Consolidated Statements of Cash Flows for the interim periods are not necessarily indicative of the results or cash flows for the full year. The Company operates on a 52-53 week fiscal year ending on the Saturday nearest to March 31 st of each year. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest March 31 st . The current fiscal year will end on March 29, 2025 and will include 52 weeks."]
["Recent Accounting Pronouncements","The Company considers the applicability and impact of all Accounting Standards Updates (\"ASUs\") issued by the Financial Accounting Standards Board (\"FASB\"). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Company's Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures, which requires greater disaggregation of income tax disclosures. The new standard requires additional information to be disclosed with respect to the income tax rate reconciliation and income taxes paid disaggregated by jurisdiction. This ASU should be applied prospectively for fiscal years beginning after December 15, 2024, with retrospective application permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires companies to enhance the disclosures about segment expenses. The new standard requires the identification and disclosure of the Company’s Chief Operating Decision Maker (\"CODM\"), expanded incremental line-item disclosures of significant segment expenses used by the CODM for decision-making, and the inclusion of previous annual only segment disclosure requirements on a quarterly basis. This ASU should be applied retrospectively for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impacts of this guidance on the Company’s Consolidated Financial Statements. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (\"ASU 2024-03\"), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (\"ASU 2025-01\"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its Consolidated Financial Statements."]
["Repurchase Contingencies","Repurchase Contingencies . The maximum amount for which the Company was liable under the terms of repurchase agreements with financial institutions that provide inventory financing to independent distributors of our products approximated $122 million and $121 million at December 28, 2024 and March 30, 2024, respectively, without reduction for the estimated resale value of the home s. In the quarter ended December 28, 2024 we received one repurchase demand notice for two homes. In all cases, the estimated fair value exceeded the repurchase price so no loss reserve was deemed necessary. Our reserve for repurchase commitments, re"]
["Representations and Warranties of Mortgages Sold","Representations and Warranties of Mortgages Sold . The reserve for contingent repurchases and indemnification obliga tions was $0.7 million as of December 28, 2024 and $0.6 million as of March 30, 2024, included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets. There were no claim requests that resulted in the repurchase of any loans during the nine months ended December 28, 2024 or December 30, 2023 ."]
["Interest Rate Lock Commitments and Forward Sales Commitments","Interest Rate Lock Commitments (\"IRLCs\") . As of December 28, 2024 and March 30, 2024, we had outstanding IRLCs with a notional amount of $10.1 million and $39.0 million, respectively. For the three and nine months ended December 28, 2024, we recognized insignificant non-cash losses and gains, respectively, on outstanding IRLCs. For the three and nine months ended December 30, 2023, we recognized insignificant non-cash gains and losses on outstanding IRLCs. Forward Sales Commitments . As of December 28, 2024 and March 30, 2024, we had $15.0 million and $2.8 million in outstanding forward sales commitments for sales of mortgage backed securities and whole loan commitments (collectively, the \"Commitments\"), respectively. During the three and nine months ended December 28, 2024, we recognized insignificant non-cash gains. During the three and nine months ended December 30, 2023, we recognized insignificant non-cash losses."]
["Mortgage Servicing","Mortgage Servicing . Mortgage Servicing Rights (\"MSRs\") are recorded at fair value in Prepaid expenses and other current assets on the Consolidated Balance Sheets."]

{"sheet":"Revenue from Contracts with C_2","index":25,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Revenue from Contracts with Customers (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Revenue from Contract with Customer [Abstract]"," "]
["Schedule of Disaggregation of Revenue","The following table summarizes Net revenue disaggregated by reportable segment and source (in thousands): Three Months Ended Nine Months Ended December 28, 2024 December 30, 2023 December 28, December 30, Factory-built housing Home sales $ 471,998 $ 400,633 $ 1,378,103 $ 1,250,417 Delivery, setup and other revenues 28,862 26,306 67,148 67,697 500,860 426,939 1,445,251 1,318,114 Financial services Insurance agency commissions received from third-party insurance companies 1,246 1,229 3,920 3,145 All other sources 19,934 18,601 57,929 53,415 21,180 19,830 61,849 56,560 $ 522,040 $ 446,769 $ 1,507,100 $ 1,374,674 "]

{"sheet":"Investments (Tables)","index":26,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Investments (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Investments, Debt and Equity Securities [Abstract]"," "]
["Schedule of Investments","Investments consisted of the following (in thousands): December 28, March 30, Available-for-sale debt securities $ 21,783 $ 18,669 Marketable equity securities 7,434 11,961 Non-marketable equity investments 5,132 4,956 34,349 35,586 Less short-term investments (16,062) (18,270) $ 18,287 $ 17,316 "]
["Schedule of Available-for-Sale Securities Reconciliation","The amortized cost and fair value of our investments in available-for-sale debt securities, by security type, are shown in the table below (in thousands): December 28, 2024 March 30, 2024 Amortized Fair Amortized Cost Fair Residential mortgage-backed securities $ 4,146 $ 4,093 $ 2,933 $ 2,865 State and political subdivision debt securities 6,565 6,515 5,041 4,930 Corporate debt securities 11,257 11,175 11,117 10,874 $ 21,968 $ 21,783 $ 19,091 $ 18,669 "]
["Schedule of Contractual Maturity of Investment Securities","The amortized cost and fair value of our investments in available-for-sale debt securities, by contractual maturity, are shown in the table below (in thousands). Expected maturities may differ from contractual maturities as borrowers at times have the right to call or prepay obligations, with or without penalties. December 28, 2024 Amortized Fair Due in less than one year $ 8,402 $ 8,332 Due after one year through five years 7,088 7,047 Due after five years through ten years 2,332 2,311 Mortgage-backed securities 4,146 4,093 $ 21,968 $ 21,783 "]
["Schedule of Gain (Loss) on Securities","Net investment gains and losses on marketable equity securities were as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Marketable equity securities Net gain (loss) recognized during the period $ (954) $ 776 $ (440) $ 1,051 Less: Net (gain) recognized on securities sold during the period (1,649) (235) (1,561) (365) Unrealized gain (loss) recognized during the period on securities still held $ (2,603) $ 541 $ (2,001) $ 686 "]

{"sheet":"Inventories (Tables)","index":27,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Inventories (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Inventory Disclosure [Abstract]"," "]
["Schedule of Inventory","Inventories consisted of the following (in thousands): December 28, March 30, Raw materials $ 78,631 $ 78,241 Work in process 30,027 27,977 Finished goods 134,641 135,121 $ 243,299 $ 241,339 "]

{"sheet":"Consumer Loans Receivable (Tabl","index":28,"n_rows":7,"n_cols":2,"rows_kept":7,"merged":[[0,0,1,0]]}
["Consumer Loans Receivable (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Receivables [Abstract]"," "]
["Schedule of Accounts, Notes, Loans and Financing Receivable","The following table summarizes consumer loans receivable (in thousands): December 28, March 30, Loans held for investment, previously securitized $ 14,476 $ 16,968 Loans held for investment 11,898 12,826 Loans held for sale 23,233 15,140 Construction advances 6,042 722 55,649 45,656 Deferred financing fees and other, net (1,088) (523) Allowance for loan losses (925) (1,066) 53,636 44,067 Less current portion (33,242) (20,713) $ 20,394 $ 23,354 Commercial loans receivable, net consisted of the following (in thousands): December 28, March 30, Loans receivable $ 94,902 $ 91,938 Allowance for loan losses (335) (781) Deferred financing fees, net (214) (116) 94,353 91,041 Less current portion of commercial loans receivable (including from affiliates), net (36,250) (43,316) $ 58,103 $ 47,725 "]
["Schedule of Consumer Loans Held for Investment Characteristics","The consumer loans held for investment had the following characteristics: December 28, March 30, Weighted average contractual interest rate 8.1 % 8.1 % Weighted average effective interest rate 8.1 % 10.4 % Weighted average months to maturity 210 196"]
["Schedule of Financing Receivable, Modified","The following table is a consolidated summary of the delinquency status of the outstanding principal balance of consumer loans receivable (in thousands): December 28, March 30, Current $ 53,709 $ 43,810 31 to 60 days 996 1,063 61 to 90 days 373 131 91+ days 571 652 $ 55,649 $ 45,656 "]
["Schedule of Financing Receivable Credit Quality Indicators","The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Prior Total Prime- FICO score 680 and greater $ 15,726 $ 9,225 $ 324 $ 93 $ 766 $ 13,859 $ 39,993 Near Prime- FICO score 620-679 2,426 1,325 — — 1,033 8,874 13,658 Sub-Prime- FICO score less than 620 310 — — — 17 695 1,022 No FICO score 252 443 — — — 281 976 $ 18,714 $ 10,993 $ 324 $ 93 $ 1,816 $ 23,709 $ 55,649 March 30, 2024 2024 2023 2022 2021 2020 Prior Total Prime- FICO score 680 and greater $ 14,107 $ 328 $ 96 $ 885 $ 1,808 $ 14,425 $ 31,649 Near Prime- FICO score 620-679 1,633 — — 1,202 942 8,684 12,461 Sub-Prime- FICO score less than 620 — — — 18 49 723 790 No FICO score 447 — — — — 309 756 $ 16,187 $ 328 $ 96 $ 2,105 $ 2,799 $ 24,141 $ 45,656 December 28, 2024 2025 2024 2023 2022 2021 Total Performing $ 54,916 $ 27,832 $ 8,734 $ 1,466 $ 1,954 $ 94,902 March 30, 2024 2024 2023 2022 2021 2020 Total Performing $ 57,691 $ 25,066 $ 4,823 $ 2,144 $ 2,214 $ 91,938 "]

{"sheet":"Commercial Loans Receivables (T","index":29,"n_rows":6,"n_cols":2,"rows_kept":6,"merged":[[0,0,1,0]]}
["Commercial Loans Receivables (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Receivables [Abstract]"," "]
["Schedule of Accounts, Notes, Loans and Financing Receivable","The following table summarizes consumer loans receivable (in thousands): December 28, March 30, Loans held for investment, previously securitized $ 14,476 $ 16,968 Loans held for investment 11,898 12,826 Loans held for sale 23,233 15,140 Construction advances 6,042 722 55,649 45,656 Deferred financing fees and other, net (1,088) (523) Allowance for loan losses (925) (1,066) 53,636 44,067 Less current portion (33,242) (20,713) $ 20,394 $ 23,354 Commercial loans receivable, net consisted of the following (in thousands): December 28, March 30, Loans receivable $ 94,902 $ 91,938 Allowance for loan losses (335) (781) Deferred financing fees, net (214) (116) 94,353 91,041 Less current portion of commercial loans receivable (including from affiliates), net (36,250) (43,316) $ 58,103 $ 47,725 "]
["Schedule of Commercial Loans Receivable Characteristics","The commercial loans receivable balance had the following characteristics: December 28, March 30, Weighted average contractual interest rate 7.7 % 7.4 % Weighted average months outstanding 10 12"]
["Schedule of Commercial Loans Receivables by Class and Internal Credit Quality Indicator","The following table disaggregates the outstanding principal balance of consumer loans receivable by credit quality indicator and fiscal year of origination (in thousands): December 28, 2024 2025 2024 2023 2022 2021 Prior Total Prime- FICO score 680 and greater $ 15,726 $ 9,225 $ 324 $ 93 $ 766 $ 13,859 $ 39,993 Near Prime- FICO score 620-679 2,426 1,325 — — 1,033 8,874 13,658 Sub-Prime- FICO score less than 620 310 — — — 17 695 1,022 No FICO score 252 443 — — — 281 976 $ 18,714 $ 10,993 $ 324 $ 93 $ 1,816 $ 23,709 $ 55,649 March 30, 2024 2024 2023 2022 2021 2020 Prior Total Prime- FICO score 680 and greater $ 14,107 $ 328 $ 96 $ 885 $ 1,808 $ 14,425 $ 31,649 Near Prime- FICO score 620-679 1,633 — — 1,202 942 8,684 12,461 Sub-Prime- FICO score less than 620 — — — 18 49 723 790 No FICO score 447 — — — — 309 756 $ 16,187 $ 328 $ 96 $ 2,105 $ 2,799 $ 24,141 $ 45,656 December 28, 2024 2025 2024 2023 2022 2021 Total Performing $ 54,916 $ 27,832 $ 8,734 $ 1,466 $ 1,954 $ 94,902 March 30, 2024 2024 2023 2022 2021 2020 Total Performing $ 57,691 $ 25,066 $ 4,823 $ 2,144 $ 2,214 $ 91,938 "]

{"sheet":"Accrued Expenses and Other Cu_2","index":30,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Accrued Expenses and Other Current Liabilities (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Payables and Accruals [Abstract]"," "]
["Schedule of Accrued Expenses and Other Current Liabilities","Accrued expenses and other current liabilities consisted of the following (in thousands): December 28, March 30, Salaries, wages and benefits $ 44,338 $ 38,125 Customer deposits 39,795 40,856 Estimated warranties 34,412 31,718 Unearned insurance premiums 33,419 33,449 Accrued volume rebates 30,481 21,167 Insurance loss reserves 12,254 10,540 Accrued insurance 12,226 14,124 Other 52,209 49,757 $ 259,134 $ 239,736 "]

{"sheet":"Warranties (Tables)","index":31,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Warranties (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Product Warranties Disclosures [Abstract]"," "]
["Schedule of Activity in the Liability for Estimated Warranties","Activity in the liability for estimated warranties was as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Balance at beginning of period $ 33,081 $ 33,015 $ 31,718 $ 31,368 Charged to costs and expenses 14,322 11,341 40,403 36,956 Payments and deductions (12,991) (11,534) (37,709) (35,502) Balance at end of period $ 34,412 $ 32,822 $ 34,412 $ 32,822 "]

{"sheet":"Other Liabilities (Tables)","index":32,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Other Liabilities (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Debt Disclosure [Abstract]"," "]
["Schedule of Other Liabilities","The following table summarizes secured financings and other obligations (in thousands): December 28, March 30, Finance lease liabilities $ 6,106 $ 6,166 Other secured financing 1,622 1,916 7,728 8,082 Less current portion included in Accrued expenses and other current liabilities (522) (323) $ 7,206 $ 7,759 "]

{"sheet":"Reinsurance and Insurance Los_2","index":33,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Reinsurance and Insurance Loss Reserves (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Insurance [Abstract]"," "]
["Schedule of Effects of Reinsurance","The effects of reinsurance on premiums written and earned were as follows (in thousands): Three Months Ended December 28, 2024 December 30, 2023 Written Earned Written Earned Direct premiums $ 19,260 $ 24,645 $ 11,135 $ 10,693 Assumed premiums—nonaffiliated 21,534 20,629 8,430 8,459 Ceded premiums—nonaffiliated (17,387) (17,387) (6,406) (6,406) $ 23,407 $ 27,887 $ 13,159 $ 12,746 Nine Months Ended December 28, 2024 December 30, 2023 Written Earned Written Earned Direct premiums $ 32,763 $ 36,947 $ 31,581 $ 28,740 Assumed premiums—nonaffiliated 33,269 30,133 27,735 25,880 Ceded premiums—nonaffiliated (25,572) (25,572) (18,971) (18,971) $ 40,460 $ 41,508 $ 40,345 $ 35,649 "]
["Schedule of Loss Reserve Rollforward","The following details the activity in the incurred but not reported reserve for the three and nine months ended December 28, 2024 a nd December 30, 2023 (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Balance at beginning of period $ 14,620 $ 9,154 $ 10,540 $ 10,939 Net incurred losses during the period 9,662 9,489 41,753 29,152 Net claim payments during the period (12,028) (9,189) (40,039) (30,637) Balance at end of period $ 12,254 $ 9,454 $ 12,254 $ 9,454 "]

{"sheet":"Commitments and Contingencies (","index":34,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Commitments and Contingencies (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Commitments and Contingencies Disclosure [Abstract]"," "]
["Schedule of Loan Contracts with Off-Balance Sheet Commitments","Construction-Period Mortgages. Loan contracts with off-balance sheet commitments are summarized below (in thousands): December 28, March 30, Construction loan contract amount $ 12,669 $ 1,960 Cumulative advances (6,042) (722) $ 6,627 $ 1,238 "]

{"sheet":"Stockholders' Equity and Rede_2","index":35,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Stockholders' Equity and Redeemable Noncontrolling Interest (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Stockholders' Equity Note [Abstract]"," "]
["Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest","The following tables represent changes in stockholders' equity attributable to Cavco's stockholders and redeemable noncontrolling interest during the nine months ended December 28, 2024 and December 30, 2023, respectively (dollars in thousands): Equity Attributable to Cavco Stockholders Treasury stock Additional paid-in capital Retained earnings Accumulated other comprehensive (loss) income Total Common Stock Shares Amount Balance, March 30, 2024 9,389,953 $ 94 $ (274,693) $ 281,216 $ 1,027,127 $ (333) $ 1,033,411 Net income — — — — 34,429 — 34,429 Other comprehensive income, net — — — — — 58 58 Net issuance of common stock under stock incentive plans 11,104 — — (2,348) — — (2,348) Stock-based compensation — — — 2,194 — — 2,194 Common stock repurchases (29,204) (29,204) Balance, June 29, 2024 9,401,057 94 (303,897) 281,062 1,061,556 (275) 1,038,540 Net income — — — — 43,815 — 43,815 Other comprehensive income, net — — — — — 198 198 Net issuance of common stock under stock incentive plans 16,275 — 1,220 — — 1,220 Stock-based compensation — — — 2,713 — — 2,713 Common stock repurchases — — (44,509) — — — (44,509) Balance, September 28, 2024 9,417,332 94 (348,406) 284,995 1,105,371 (77) 1,041,977 Net income — — — — 56,462 — 56,462 Other comprehensive income, net — — — — — (70) (70) Net issuance of common stock under stock incentive plans 5,637 — — (168) — — (168) Stock-based compensation — — — 1,746 — — 1,746 Common stock repurchases — — (42,722) — — — (42,722) Balance, December 28, 2024 9,422,969 $ 94 $ (391,128) $ 286,573 $ 1,161,833 $ (147) $ 1,057,225 Equity Attributable to Cavco Stockholders Treasury stock Additional paid-in capital Retained earnings Accumulated other comprehensive (loss) income Total Redeemable noncontrolling interest Common Stock Shares Amount Balance, April 1, 2023 9,337,125 $ 93 $ (164,452) $ 271,950 $ 869,310 $ (615) $ 976,286 $ 1,219 Net income — — — — 46,357 — 46,357 54 Other comprehensive loss, net — — — — — (42) (42) — Net issuance of common stock under stock incentive plans 10,095 — — (1,213) — — (1,213) — Stock-based compensation — — — 1,438 — — 1,438 — Distributions — — — — — — — (120) Valuation adjustment — — — — — — — (33) Balance, July 1, 2023 9,347,220 93 (164,452) 272,175 915,667 (657) 1,022,826 1,120 Net income — — — — 41,539 — 41,539 34 Other comprehensive income, net — — — — — 54 54 — Net issuance of common stock under stock incentive plans 9,201 1 — 478 — — 479 — Stock-based compensation — — — 1,551 — — 1,551 — Common stock repurchases — — (47,194) — — — (47,194) — Distributions — — — — — — — (180) Conversion to mandatorily redeemable noncontrolling interest — — — — — — — (974) Balance, September 30, 2023 9,356,421 94 (211,646) 274,204 957,206 (603) 1,019,255 — Net income — — — — 35,987 — 35,987 — Other comprehensive income, net — — — — — 241 241 — Net issuance of common stock under stock incentive plans 24,726 — — 1,934 — — 1,934 — Stock-based compensation — — — 1,709 — — 1,709 — Common stock repurchases — — (50,426) — — — (50,426) — Balance, December 30, 2023 9,381,147 $ 94 $ (262,072) $ 277,847 $ 993,193 $ (362) $ 1,008,700 $ — "]

{"sheet":"Earnings Per Share (Tables)","index":36,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Earnings Per Share (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Earnings Per Share [Abstract]"," "]
["Schedule of Earnings Per Share","The following table sets forth the computation of basic and diluted earnings per share (dollars in thousands, except per share amounts): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Net income attributable to Cavco common stockholders $ 56,462 $ 35,987 $ 134,706 $ 123,883 Weighted average shares outstanding Basic 8,096,538 8,358,389 8,203,448 8,561,209 Effect of dilutive securities 90,276 74,082 88,199 79,079 Diluted 8,186,814 8,432,471 8,291,647 8,640,288 Net income per share attributable to Cavco common stockholders Basic $ 6.97 $ 4.31 $ 16.42 $ 14.47 Diluted $ 6.90 $ 4.27 $ 16.25 $ 14.34 Anti-dilutive common stock equivalents excluded — — 169 316 "]

{"sheet":"Fair Value Measurements (Tables","index":37,"n_rows":5,"n_cols":2,"rows_kept":5,"merged":[[0,0,1,0]]}
["Fair Value Measurements (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Fair Value Disclosures [Abstract]"," "]
["Schedule of the Fair Value and Carrying Value of Financial Instruments","The book value and estimated fair value of our financial instruments were as follows (in thousands): December 28, 2024 March 30, 2024 Book Estimated Book Estimated Available-for-sale debt securities $ 21,783 $ 21,783 $ 18,669 $ 18,669 Marketable equity securities 7,434 7,434 11,961 11,961 Non-marketable equity investments 5,132 5,132 4,956 4,956 Consumer loans receivable 53,636 57,114 44,067 49,105 Commercial loans receivable 94,353 79,664 91,041 80,764 Other secured financing (1,622) (1,536) (1,916) (1,841)"]
["Schedule of Assumptions for Mortgage Servicing Rights","December 28, March 30, Number of loans serviced with MSRs 3,693 3,842 Weighted average servicing fee (basis points) 34.80 34.79 Capitalized servicing multiple 186.29 % 188.59 % Capitalized servicing rate (basis points) 64.83 65.61 Serviced portfolio with MSRs (in thousands) $ 458,268 $ 482,898 MSRs (in thousands) $ 2,971 $ 3,168 "]

{"sheet":"Business Segment Information (T","index":38,"n_rows":4,"n_cols":2,"rows_kept":4,"merged":[[0,0,1,0]]}
["Business Segment Information (Tables)","9 Months Ended"]
[null,"Dec. 28, 2024"]
["Segment Reporting [Abstract]"," "]
["Schedule of Business Segment Information","The following table provides selected financial data by segment (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, Net revenue: Factory-built housing $ 500,860 $ 426,939 $ 1,445,251 $ 1,318,114 Financial services 21,180 19,830 61,849 56,560 $ 522,040 $ 446,769 $ 1,507,100 $ 1,374,674 Income (loss) before income taxes: Factory-built housing $ 63,150 $ 42,070 $ 168,155 $ 154,121 Financial services 6,186 1,837 (8) 2,124 $ 69,336 $ 43,907 $ 168,147 $ 156,245 December 28, March 30, Total assets: Factory-built housing $ 1,160,795 $ 1,141,237 Financial services 224,972 212,923 $ 1,385,767 $ 1,354,160 "]

{"sheet":"Revenue from Contracts with C_3","index":39,"n_rows":22,"n_cols":5,"rows_kept":22,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":522040,"d":"$ 522,040"},{"v":446769,"d":"$ 446,769"},{"v":1507100,"d":"$ 1,507,100"},{"v":1374674,"d":"$ 1,374,674"}]
["Factory-built housing"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":500860,"d":"500,860 "},{"v":426939,"d":"426,939 "},{"v":1445251,"d":"1,445,251 "},{"v":1318114,"d":"1,318,114 "}]
["Factory-built housing | Home sales"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":471998,"d":"471,998 "},{"v":400633,"d":"400,633 "},{"v":1378103,"d":"1,378,103 "},{"v":1250417,"d":"1,250,417 "}]
["Factory-built housing | Delivery, setup and other revenues"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":28862,"d":"28,862 "},{"v":26306,"d":"26,306 "},{"v":67148,"d":"67,148 "},{"v":67697,"d":"67,697 "}]
["Financial services"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":21180,"d":"21,180 "},{"v":19830,"d":"19,830 "},{"v":61849,"d":"61,849 "},{"v":56560,"d":"56,560 "}]
["Financial services | Insurance agency commissions received from third-party insurance companies"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":1246,"d":"1,246 "},{"v":1229,"d":"1,229 "},{"v":3920,"d":"3,920 "},{"v":3145,"d":"3,145 "}]
["Financial services | All other sources"," "," "," "," "]
["Disaggregation of Revenue [Line Items]"," "," "," "," "]
["Net revenue",{"v":19934,"d":"$ 19,934"},{"v":18601,"d":"$ 18,601"},{"v":57929,"d":"$ 57,929"},{"v":53415,"d":"$ 53,415"}]

{"sheet":"Investments - Schedule of Inves","index":40,"n_rows":8,"n_cols":3,"rows_kept":8}
["Investments - Schedule of Investments (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Investments, Debt and Equity Securities [Abstract]"," "," "]
["Available-for-sale debt securities",{"v":21783,"d":"$ 21,783"},{"v":18669,"d":"$ 18,669"}]
["Marketable equity securities",{"v":7434,"d":"7,434 "},{"v":11961,"d":"11,961 "}]
["Non-marketable equity investments",{"v":5132,"d":"5,132 "},{"v":4956,"d":"4,956 "}]
["Investments",{"v":34349,"d":"34,349 "},{"v":35586,"d":"35,586 "}]
["Less short-term investments",{"v":-16062,"d":"(16,062)"},{"v":-18270,"d":"(18,270)"}]
["Investments",{"v":18287,"d":"$ 18,287"},{"v":17316,"d":"$ 17,316"}]

{"sheet":"Investments - Schedule of Amort","index":41,"n_rows":16,"n_cols":3,"rows_kept":16}
["Investments - Schedule of Amortized Cost and Fair Value (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Debt Securities, Available-for-sale [Line Items]"," "," "]
["Amortized Cost",{"v":21968,"d":"$ 21,968"},{"v":19091,"d":"$ 19,091"}]
["Fair Value",{"v":21783,"d":"21,783 "},{"v":18669,"d":"18,669 "}]
["Residential mortgage-backed securities"," "," "]
["Debt Securities, Available-for-sale [Line Items]"," "," "]
["Amortized Cost",{"v":4146,"d":"4,146 "},{"v":2933,"d":"2,933 "}]
["Fair Value",{"v":4093,"d":"4,093 "},{"v":2865,"d":"2,865 "}]
["State and political subdivision debt securities"," "," "]
["Debt Securities, Available-for-sale [Line Items]"," "," "]
["Amortized Cost",{"v":6565,"d":"6,565 "},{"v":5041,"d":"5,041 "}]
["Fair Value",{"v":6515,"d":"6,515 "},{"v":4930,"d":"4,930 "}]
["Corporate debt securities"," "," "]
["Debt Securities, Available-for-sale [Line Items]"," "," "]
["Amortized Cost",{"v":11257,"d":"11,257 "},{"v":11117,"d":"11,117 "}]
["Fair Value",{"v":11175,"d":"$ 11,175"},{"v":10874,"d":"$ 10,874"}]

{"sheet":"Investments - Schedule of Contr","index":42,"n_rows":13,"n_cols":3,"rows_kept":13}
["Investments - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Amortized Cost"," "," "]
["Due in less than one year",{"v":8402,"d":"$ 8,402"}," "]
["Due after one year through five years",{"v":7088,"d":"7,088 "}," "]
["Due after five years through ten years",{"v":2332,"d":"2,332 "}," "]
["Mortgage-backed securities",{"v":4146,"d":"4,146 "}," "]
["Amortized Cost",{"v":21968,"d":"21,968 "},{"v":19091,"d":"$ 19,091"}]
["Fair Value"," "," "]
["Due in less than one year",{"v":8332,"d":"8,332 "}," "]
["Due after one year through five years",{"v":7047,"d":"7,047 "}," "]
["Due after five years through ten years",{"v":2311,"d":"2,311 "}," "]
["Mortgage-backed securities",{"v":4093,"d":"4,093 "}," "]
["Fair Value",{"v":21783,"d":"$ 21,783"},{"v":18669,"d":"$ 18,669"}]

{"sheet":"Investments - Schedule of Recog","index":43,"n_rows":6,"n_cols":5,"rows_kept":6,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Investments - Schedule of Recognized Gains and Losses (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Investments, Debt and Equity Securities [Abstract]"," "," "," "," "]
["Net gain (loss) recognized during the period",{"v":-954,"d":"$ (954)"},{"v":776,"d":"$ 776"},{"v":-440,"d":"$ (440)"},{"v":1051,"d":"$ 1,051"}]
["Less: Net (gain) recognized on securities sold during the period",{"v":-1649,"d":"(1,649)"},{"v":-235,"d":"(235)"},{"v":-1561,"d":"(1,561)"},{"v":-365,"d":"(365)"}]
["Unrealized gain (loss) recognized during the period on securities still held",{"v":-2603,"d":"$ (2,603)"},{"v":541,"d":"$ 541"},{"v":-2001,"d":"$ (2,001)"},{"v":686,"d":"$ 686"}]

{"sheet":"Inventories (Details)","index":44,"n_rows":6,"n_cols":3,"rows_kept":6}
["Inventories (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Summary of inventories"," "," "]
["Raw materials",{"v":78631,"d":"$ 78,631"},{"v":78241,"d":"$ 78,241"}]
["Work in process",{"v":30027,"d":"30,027 "},{"v":27977,"d":"27,977 "}]
["Finished goods",{"v":134641,"d":"134,641 "},{"v":135121,"d":"135,121 "}]
["Total inventories",{"v":243299,"d":"$ 243,299"},{"v":241339,"d":"$ 241,339"}]

{"sheet":"Consumer Loans Receivable - Sch","index":45,"n_rows":15,"n_cols":3,"rows_kept":15}
["Consumer Loans Receivable - Schedule of Consumer Loans Receivable (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Construction advances",{"v":6042,"d":"$ 6,042"},{"v":722,"d":"$ 722"}]
["Consumer Loans Receivable"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans held for investment, previously securitized",{"v":14476,"d":"14,476 "},{"v":16968,"d":"16,968 "}]
["Loans held for investment",{"v":11898,"d":"11,898 "},{"v":12826,"d":"12,826 "}]
["Loans held for sale",{"v":23233,"d":"23,233 "},{"v":15140,"d":"15,140 "}]
["Construction advances",{"v":6042,"d":"6,042 "},{"v":722,"d":"722 "}]
["Loans receivable, gross",{"v":55649,"d":"55,649 "},{"v":45656,"d":"45,656 "}]
["Deferred financing fees and other, net",{"v":-1088,"d":"(1,088)"},{"v":-523,"d":"(523)"}]
["Allowance for loan losses",{"v":-925,"d":"(925)"},{"v":-1066,"d":"(1,066)"}]
["Loans receivable, net",{"v":53636,"d":"53,636 "},{"v":44067,"d":"44,067 "}]
["Less current portion",{"v":-33242,"d":"(33,242)"},{"v":-20713,"d":"(20,713)"}]
["Loans receivable, net",{"v":20394,"d":"$ 20,394"},{"v":23354,"d":"$ 23,354"}]

{"sheet":"Consumer Loans Receivable - S_2","index":46,"n_rows":6,"n_cols":3,"rows_kept":6,"merged":[[0,0,1,0]]}
["Consumer Loans Receivable - Schedule of Weighted Averages (Details) - Consumer Loans Receivable","9 Months Ended","12 Months Ended"]
[null,"Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Weighted average contractual interest rate",{"v":0.081,"d":"8.10%"},{"v":0.081,"d":"8.10%"}]
["Weighted average effective interest rate",{"v":0.081,"d":"8.10%"},{"v":0.104,"d":"10.40%"}]
["Weighted average months to maturity","210 months","196 months"]

{"sheet":"Consumer Loans Receivable - S_3","index":47,"n_rows":16,"n_cols":3,"rows_kept":16,"merged":[[0,0,1,0]]}
["Consumer Loans Receivable - Schedule of Delinquency Status of Consumer Loans (Details) - Consumer Loans Receivable - USD ($) $ in Thousands","9 Months Ended","12 Months Ended"]
[null,"Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":55649,"d":"$ 55,649"},{"v":45656,"d":"$ 45,656"}]
["Current"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":53709,"d":"53,709 "},{"v":43810,"d":"43,810 "}]
["31 to 60 days"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":996,"d":"996 "},{"v":1063,"d":"1,063 "}]
["61 to 90 days"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":373,"d":"373 "},{"v":131,"d":"131 "}]
["91+ days"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":571,"d":"$ 571"},{"v":652,"d":"$ 652"}]

{"sheet":"Consumer Loans Receivable - S_4","index":48,"n_rows":45,"n_cols":3,"rows_kept":45}
["Consumer Loans Receivable - Schedule of Consumer Loan Receivables by Segment and Credit Quality Indicator (Details) - Consumer Loans Receivable - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans by origination year, one",{"v":18714,"d":"$ 18,714"},{"v":16187,"d":"$ 16,187"}]
["Loans by origination year, two",{"v":10993,"d":"10,993 "},{"v":328,"d":"328 "}]
["Loans by origination year, three",{"v":324,"d":"324 "},{"v":96,"d":"96 "}]
["Loans by origination year, four",{"v":93,"d":"93 "},{"v":2105,"d":"2,105 "}]
["Loans by origination year, five",{"v":1816,"d":"1,816 "},{"v":2799,"d":"2,799 "}]
["Prior",{"v":23709,"d":"23,709 "},{"v":24141,"d":"24,141 "}]
["Loans receivable, gross",{"v":55649,"d":"55,649 "},{"v":45656,"d":"45,656 "}]
["Prime- FICO score 680 and greater"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans by origination year, one",{"v":15726,"d":"15,726 "},{"v":14107,"d":"14,107 "}]
["Loans by origination year, two",{"v":9225,"d":"9,225 "},{"v":328,"d":"328 "}]
["Loans by origination year, three",{"v":324,"d":"324 "},{"v":96,"d":"96 "}]
["Loans by origination year, four",{"v":93,"d":"93 "},{"v":885,"d":"885 "}]
["Loans by origination year, five",{"v":766,"d":"766 "},{"v":1808,"d":"1,808 "}]
["Prior",{"v":13859,"d":"13,859 "},{"v":14425,"d":"14,425 "}]
["Loans receivable, gross",{"v":39993,"d":"39,993 "},{"v":31649,"d":"31,649 "}]
["Near Prime- FICO score 620-679"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans by origination year, one",{"v":2426,"d":"2,426 "},{"v":1633,"d":"1,633 "}]
["Loans by origination year, two",{"v":1325,"d":"1,325 "},{"v":0,"d":"0 "}]
["Loans by origination year, three",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Loans by origination year, four",{"v":0,"d":"0 "},{"v":1202,"d":"1,202 "}]
["Loans by origination year, five",{"v":1033,"d":"1,033 "},{"v":942,"d":"942 "}]
["Prior",{"v":8874,"d":"8,874 "},{"v":8684,"d":"8,684 "}]
["Loans receivable, gross",{"v":13658,"d":"13,658 "},{"v":12461,"d":"12,461 "}]
["Sub-Prime- FICO score less than 620"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans by origination year, one",{"v":310,"d":"310 "},{"v":0,"d":"0 "}]
["Loans by origination year, two",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Loans by origination year, three",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Loans by origination year, four",{"v":0,"d":"0 "},{"v":18,"d":"18 "}]
["Loans by origination year, five",{"v":17,"d":"17 "},{"v":49,"d":"49 "}]
["Prior",{"v":695,"d":"695 "},{"v":723,"d":"723 "}]
["Loans receivable, gross",{"v":1022,"d":"1,022 "},{"v":790,"d":"790 "}]
["No FICO score"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans by origination year, one",{"v":252,"d":"252 "},{"v":447,"d":"447 "}]
["Loans by origination year, two",{"v":443,"d":"443 "},{"v":0,"d":"0 "}]
["Loans by origination year, three",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Loans by origination year, four",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Loans by origination year, five",{"v":0,"d":"0 "},{"v":0,"d":"0 "}]
["Prior",{"v":281,"d":"281 "},{"v":309,"d":"309 "}]
["Loans receivable, gross",{"v":976,"d":"$ 976"},{"v":756,"d":"$ 756"}]

{"sheet":"Consumer Loans Receivable - Nar","index":49,"n_rows":8,"n_cols":3,"rows_kept":8,"merged":[[0,0,1,0]]}
["Consumer Loans Receivable - Narrative (Details) - Financing Receivable - Geographic Concentration Risk - Consumer Loans Receivable","9 Months Ended","12 Months Ended"]
[null,"Dec. 28, 2024","Mar. 30, 2024"]
["TEXAS"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Concentration risk, percentage",{"v":0.55,"d":"55%"},{"v":0.46,"d":"46%"}]
["FLORIDA"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Concentration risk, percentage"," ",{"v":0.1,"d":"10%"}]

{"sheet":"Commercial Loans Receivable - S","index":50,"n_rows":8,"n_cols":3,"rows_kept":8}
["Commercial Loans Receivable - Schedule of Commercial Loans Notes Receivables, Net (Details) - Commercial Loans Receivable - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Loans receivable",{"v":94902,"d":"$ 94,902"},{"v":91938,"d":"$ 91,938"}]
["Allowance for loan losses",{"v":-335,"d":"(335)"},{"v":-781,"d":"(781)"}]
["Deferred financing fees, net",{"v":-214,"d":"(214)"},{"v":-116,"d":"(116)"}]
["Loans receivable, net",{"v":94353,"d":"94,353 "},{"v":91041,"d":"91,041 "}]
["Less current portion of commercial loans receivable (including from affiliates), net",{"v":-36250,"d":"(36,250)"},{"v":-43316,"d":"(43,316)"}]
["Loans receivable, net",{"v":58103,"d":"$ 58,103"},{"v":47725,"d":"$ 47,725"}]

{"sheet":"Commercial Loans Receivable -_2","index":51,"n_rows":5,"n_cols":3,"rows_kept":5,"merged":[[0,0,1,0]]}
["Commercial Loans Receivable - Schedule of Commercial Loans Characteristics (Details) - Commercial Loans Receivable","9 Months Ended","12 Months Ended"]
[null,"Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Weighted average contractual interest rate",{"v":0.077,"d":"7.70%"},{"v":0.074,"d":"7.40%"}]
["Weighted average months outstanding","10 months","12 months"]

{"sheet":"Commercial Loans Receivable - N","index":52,"n_rows":15,"n_cols":3,"rows_kept":15,"merged":[[0,0,1,0]]}
["Commercial Loans Receivable - Narrative (Details) - Commercial Loans Receivable - USD ($)","9 Months Ended","12 Months Ended"]
[null,"Dec. 28, 2024","Mar. 30, 2024"]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Financing receivable, nonperforming, threshold","90 days"," "]
["Commercial loans 90 days past due still accruing interest",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}]
["Financing receivable, nonaccrual, threshold period past due","90 days","90 days"]
["Financing Receivable | Customer Concentration Risk"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Concentration risk, percentage",{"v":0.1,"d":"10%"},{"v":0.13,"d":"13%"}]
["NEW YORK | Financing Receivable | Geographic Concentration Risk"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Concentration risk, percentage",{"v":0.18,"d":"18%"},{"v":0.18,"d":"18%"}]
["CALIFORNIA | Financing Receivable | Geographic Concentration Risk"," "," "]
["Accounts, Notes, Loans and Financing Receivable [Line Items]"," "," "]
["Concentration risk, percentage",{"v":0.16,"d":"16%"}," "]

{"sheet":"Commercial Loans Receivable -_3","index":53,"n_rows":11,"n_cols":3,"rows_kept":11}
["Commercial Loans Receivable - Schedule of Commercial Loans Receivables by Credit Quality Indicator and Year of Origination (Details) - Commercial Loans Receivable - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Financing Receivable Recorded Investment [Line Items]"," "," "]
["Loans receivable, gross",{"v":94902,"d":"$ 94,902"},{"v":91938,"d":"$ 91,938"}]
["Performing"," "," "]
["Financing Receivable Recorded Investment [Line Items]"," "," "]
["Loans by origination year, one",{"v":54916,"d":"54,916 "},{"v":57691,"d":"57,691 "}]
["Loans by origination year, two",{"v":27832,"d":"27,832 "},{"v":25066,"d":"25,066 "}]
["Loans by origination year, three",{"v":8734,"d":"8,734 "},{"v":4823,"d":"4,823 "}]
["Loans by origination year, four",{"v":1466,"d":"1,466 "},{"v":2144,"d":"2,144 "}]
["Loans by origination year, five",{"v":1954,"d":"1,954 "},{"v":2214,"d":"2,214 "}]
["Loans receivable, gross",{"v":94902,"d":"$ 94,902"},{"v":91938,"d":"$ 91,938"}]

{"sheet":"Accrued Expenses and Other Cu_3","index":54,"n_rows":11,"n_cols":7,"rows_kept":11}
["Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Sep. 28, 2024","Mar. 30, 2024","Dec. 30, 2023","Sep. 30, 2023","Apr. 01, 2023"]
["Accrued Expenses and Other Current Liabilities"," "," "," "," "," "," "]
["Salaries, wages and benefits",{"v":44338,"d":"$ 44,338"}," ",{"v":38125,"d":"$ 38,125"}," "," "," "]
["Customer deposits",{"v":39795,"d":"39,795 "}," ",{"v":40856,"d":"40,856 "}," "," "," "]
["Estimated warranties",{"v":34412,"d":"34,412 "}," ",{"v":31718,"d":"31,718 "}," "," "," "]
["Unearned insurance premiums",{"v":33419,"d":"33,419 "}," ",{"v":33449,"d":"33,449 "}," "," "," "]
["Accrued volume rebates",{"v":30481,"d":"30,481 "}," ",{"v":21167,"d":"21,167 "}," "," "," "]
["Insurance loss reserves",{"v":12254,"d":"12,254 "},{"v":14620,"d":"$ 14,620"},{"v":10540,"d":"10,540 "},{"v":9454,"d":"$ 9,454"},{"v":9154,"d":"$ 9,154"},{"v":10939,"d":"$ 10,939"}]
["Accrued insurance",{"v":12226,"d":"12,226 "}," ",{"v":14124,"d":"14,124 "}," "," "," "]
["Other",{"v":52209,"d":"52,209 "}," ",{"v":49757,"d":"49,757 "}," "," "," "]
["Total accrued expenses and other current liabilities",{"v":259134,"d":"$ 259,134"}," ",{"v":239736,"d":"$ 239,736"}," "," "," "]

{"sheet":"Warranties (Details)","index":55,"n_rows":7,"n_cols":5,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Warranties (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Accrual for estimated warranties"," "," "," "," "]
["Balance at beginning of period",{"v":33081,"d":"$ 33,081"},{"v":33015,"d":"$ 33,015"},{"v":31718,"d":"$ 31,718"},{"v":31368,"d":"$ 31,368"}]
["Charged to costs and expenses",{"v":14322,"d":"14,322 "},{"v":11341,"d":"11,341 "},{"v":40403,"d":"40,403 "},{"v":36956,"d":"36,956 "}]
["Payments and deductions",{"v":-12991,"d":"(12,991)"},{"v":-11534,"d":"(11,534)"},{"v":-37709,"d":"(37,709)"},{"v":-35502,"d":"(35,502)"}]
["Balance at end of period",{"v":34412,"d":"$ 34,412"},{"v":32822,"d":"$ 32,822"},{"v":34412,"d":"$ 34,412"},{"v":32822,"d":"$ 32,822"}]

{"sheet":"Other Liabilities (Details)","index":56,"n_rows":7,"n_cols":3,"rows_kept":7}
["Other Liabilities (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Debt Obligations"," "," "]
["Finance lease liabilities",{"v":6106,"d":"$ 6,106"},{"v":6166,"d":"$ 6,166"}]
["Other secured financing",{"v":1622,"d":"1,622 "},{"v":1916,"d":"1,916 "}]
["Other liabilities",{"v":7728,"d":"7,728 "},{"v":8082,"d":"8,082 "}]
["Less current portion included in Accrued expenses and other current liabilities",{"v":-522,"d":"(522)"},{"v":-323,"d":"(323)"}]
["Other noncurrent liabilities",{"v":7206,"d":"$ 7,206"},{"v":7759,"d":"$ 7,759"}]

{"sheet":"Debt (Details)","index":57,"n_rows":33,"n_cols":4,"rows_kept":33}
["Debt (Details) - Revolving Credit Facility - Line of Credit","Nov. 12, 2024 USD ($)","Dec. 28, 2024 USD ($)","Mar. 30, 2024 USD ($)"]
["The Revolving Credit Facility"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Current borrowing capacity",{"v":75000000,"d":"$ 75,000,000"}," "," "]
["Line of credit facility, unused capacity, commitment fee percentage",{"v":0.002,"d":"0.20%"}," "," "]
["Maximum borrowing capacity",{"v":75000000,"d":"$ 75,000,000"}," "," "]
["Debt instrument, covenant, leverage ratio",3.25," "," "]
["Debt instrument, covenant, EBITDA threshold, minimum",{"v":75000000,"d":"$ 75,000,000"}," "," "]
["Long-term debt"," ",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"}]
["The Revolving Credit Facility | Secured Overnight Financing Rate (SOFR)"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, basis spread on variable rate",{"v":0.001,"d":"0.10%"}," "," "]
["The Revolving Credit Facility | Federal Funds Rate"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, basis spread on variable rate",{"v":0.005,"d":"0.50%"}," "," "]
["The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR)"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, basis spread on variable rate",{"v":0.01,"d":"1%"}," "," "]
["The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR) | Minimum [Member]"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, covenant, leverage ratio, percentage",0.0125," "," "]
["The Revolving Credit Facility | Term Secured Overnight Financing Rate (SOFR) | Maximum [Member]"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, covenant, leverage ratio, percentage",{"v":0.015,"d":"0.0150"}," "," "]
["The Revolving Credit Facility | Base Rate | Minimum [Member]"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, covenant, leverage ratio, percentage",0.0025," "," "]
["The Revolving Credit Facility | Base Rate | Maximum [Member]"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Debt instrument, covenant, leverage ratio, percentage",{"v":0.005,"d":"0.0050"}," "," "]
["Revolving Credit Facility, Sub-Facility"," "," "," "]
["Line of Credit Facility [Line Items]"," "," "," "]
["Current borrowing capacity",{"v":10000000,"d":"$ 10,000,000"}," "," "]

{"sheet":"Reinsurance and Insurance Los_3","index":58,"n_rows":12,"n_cols":5,"rows_kept":12,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Reinsurance and Insurance Loss Reserves - Schedule of Reinsurance Effect on Premiums Written and Earned (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Written"," "," "," "," "]
["Direct premiums",{"v":19260,"d":"$ 19,260"},{"v":11135,"d":"$ 11,135"},{"v":32763,"d":"$ 32,763"},{"v":31581,"d":"$ 31,581"}]
["Assumed premiums—nonaffiliated",{"v":21534,"d":"21,534 "},{"v":8430,"d":"8,430 "},{"v":33269,"d":"33,269 "},{"v":27735,"d":"27,735 "}]
["Ceded premiums—nonaffiliated",{"v":-17387,"d":"(17,387)"},{"v":-6406,"d":"(6,406)"},{"v":-25572,"d":"(25,572)"},{"v":-18971,"d":"(18,971)"}]
["Net premiums written",{"v":23407,"d":"23,407 "},{"v":13159,"d":"13,159 "},{"v":40460,"d":"40,460 "},{"v":40345,"d":"40,345 "}]
["Earned"," "," "," "," "]
["Direct premiums",{"v":24645,"d":"24,645 "},{"v":10693,"d":"10,693 "},{"v":36947,"d":"36,947 "},{"v":28740,"d":"28,740 "}]
["Assumed premiums—nonaffiliated",{"v":20629,"d":"20,629 "},{"v":8459,"d":"8,459 "},{"v":30133,"d":"30,133 "},{"v":25880,"d":"25,880 "}]
["Ceded premiums—nonaffiliated",{"v":-17387,"d":"(17,387)"},{"v":-6406,"d":"(6,406)"},{"v":-25572,"d":"(25,572)"},{"v":-18971,"d":"(18,971)"}]
["Net premiums earned",{"v":27887,"d":"$ 27,887"},{"v":12746,"d":"$ 12,746"},{"v":41508,"d":"$ 41,508"},{"v":35649,"d":"$ 35,649"}]

{"sheet":"Reinsurance and Insurance Los_4","index":59,"n_rows":8,"n_cols":2,"rows_kept":8,"merged":[[0,0,1,0]]}
["Reinsurance and Insurance Loss Reserves - Narrative (Details) $ in Thousands","9 Months Ended"]
[null,"Dec. 28, 2024 USD ($)"]
["Insurance [Abstract]"," "]
["Insurance policies maximum coverage per claim",{"v":400,"d":"$ 400"}]
["Insurance policies coverage per claim ceded to reinsurers",{"v":150,"d":"150 "}]
["Insurance policy risk of loss maintained per claim",{"v":250,"d":"250 "}]
["Catastrophic losses recoverable in excess of amount",{"v":4000,"d":"4,000 "}]
["Aggregate catastrophic losses recoverable in excess of amount",{"v":110000,"d":"$ 110,000"}]

{"sheet":"Reinsurance and Insurance Los_5","index":60,"n_rows":7,"n_cols":5,"rows_kept":7,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Reinsurance and Insurance Loss Reserves - Schedule of Loss Reserve Rollforward (Details) - USD ($) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense [Roll Forward]"," "," "," "," "]
["Balance at beginning of period",{"v":14620,"d":"$ 14,620"},{"v":9154,"d":"$ 9,154"},{"v":10540,"d":"$ 10,540"},{"v":10939,"d":"$ 10,939"}]
["Net incurred losses during the period",{"v":9662,"d":"9,662 "},{"v":9489,"d":"9,489 "},{"v":41753,"d":"41,753 "},{"v":29152,"d":"29,152 "}]
["Net claim payments during the period",{"v":-12028,"d":"(12,028)"},{"v":-9189,"d":"(9,189)"},{"v":-40039,"d":"(40,039)"},{"v":-30637,"d":"(30,637)"}]
["Balance at end of period",{"v":12254,"d":"$ 12,254"},{"v":9454,"d":"$ 9,454"},{"v":12254,"d":"$ 12,254"},{"v":9454,"d":"$ 9,454"}]

{"sheet":"Commitments and Contingencies -","index":61,"n_rows":10,"n_cols":3,"rows_kept":10,"merged":[[0,0,1,0]]}
["Commitments and Contingencies - Narrative (Details) $ in Millions","3 Months Ended"]
[null,"Dec. 28, 2024 USD ($) home demandNotice","Mar. 30, 2024 USD ($)"]
["Commitments and Contingencies Disclosure [Abstract]"," "," "]
["Repurchase agreements maximum amount contingently liable",{"v":122,"d":"$ 122"},{"v":121,"d":"$ 121"}]
["Number of repurchase demand notice | demandNotice",{"v":1,"d":"1 "}," "]
["Number of homes | home",{"v":2,"d":"2 "}," "]
["Reserve for repurchase commitments",{"v":3.2,"d":"$ 3.2"},2.9]
["Reserves related to consumer loans sold",0.7,0.6]
["IRLCs recorded at fair value",10.1,{"v":39,"d":"39 "}]
["Forward commitments recorded at fair value",{"v":15,"d":"$ 15"},{"v":2.8,"d":"$ 2.8"}]

{"sheet":"Commitments and Contingencies_2","index":62,"n_rows":5,"n_cols":3,"rows_kept":5}
["Commitments and Contingencies - Schedule of Loan Contracts with Off-Balance Sheet Commitments (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Commitments and Contingencies Disclosure [Abstract]"," "," "]
["Construction loan contract amount",{"v":12669,"d":"$ 12,669"},{"v":1960,"d":"$ 1,960"}]
["Cumulative advances",{"v":-6042,"d":"(6,042)"},{"v":-722,"d":"(722)"}]
["Remaining construction contingent commitment",{"v":6627,"d":"$ 6,627"},{"v":1238,"d":"$ 1,238"}]

{"sheet":"Stockholders' Equity and Rede_3","index":63,"n_rows":48,"n_cols":7,"rows_kept":48,"merged":[[0,0,1,0],[0,1,0,6]]}
["Stockholders' Equity and Redeemable Noncontrolling Interest (Details) - USD ($) $ in Thousands","3 Months Ended"]
[null,"Dec. 28, 2024","Sep. 28, 2024","Jun. 29, 2024","Dec. 30, 2023","Sep. 30, 2023","Jul. 01, 2023"]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance, common stock (in shares)"," "," ",{"v":8320718,"d":"8,320,718 "}," "," "," "]
["Beginning balance",{"v":1041977,"d":"$ 1,041,977"},{"v":1038540,"d":"$ 1,038,540"},{"v":1033411,"d":"$ 1,033,411"},{"v":1019255,"d":"$ 1,019,255"},{"v":1022826,"d":"$ 1,022,826"},{"v":976286,"d":"$ 976,286"}]
["Net income",{"v":56462,"d":"56,462 "},{"v":43815,"d":"43,815 "},{"v":34429,"d":"34,429 "},{"v":35987,"d":"35,987 "},{"v":41539,"d":"41,539 "},{"v":46357,"d":"46,357 "}]
["Other comprehensive income (loss), net",{"v":-70,"d":"(70)"},{"v":198,"d":"198 "},{"v":58,"d":"58 "},{"v":241,"d":"241 "},{"v":54,"d":"54 "},{"v":-42,"d":"(42)"}]
["Net issuance of common stock under stock incentive plans",{"v":-168,"d":"(168)"},{"v":1220,"d":"1,220 "},{"v":-2348,"d":"(2,348)"},{"v":1934,"d":"1,934 "},{"v":479,"d":"479 "},{"v":-1213,"d":"(1,213)"}]
["Stock-based compensation",{"v":1746,"d":"1,746 "},{"v":2713,"d":"2,713 "},{"v":2194,"d":"2,194 "},{"v":1709,"d":"1,709 "},{"v":1551,"d":"1,551 "},{"v":1438,"d":"1,438 "}]
["Common stock repurchases",{"v":-42722,"d":"$ (42,722)"},{"v":-44509,"d":"(44,509)"},{"v":-29204,"d":"(29,204)"},{"v":-50426,"d":"(50,426)"},{"v":-47194,"d":"(47,194)"}," "]
["Ending balance, common stock (in shares)",{"v":8066549,"d":"8,066,549 "}," "," "," "," "," "]
["Ending balance",{"v":1057225,"d":"$ 1,057,225"},{"v":1041977,"d":"$ 1,041,977"},{"v":1038540,"d":"$ 1,038,540"},{"v":1008700,"d":"1,008,700 "},{"v":1019255,"d":"1,019,255 "},{"v":1022826,"d":"1,022,826 "}]
["Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance"," "," "," ",{"v":0,"d":"0 "},{"v":1120,"d":"1,120 "},{"v":1219,"d":"1,219 "}]
["Net income"," "," "," "," ",{"v":34,"d":"34 "},{"v":54,"d":"54 "}]
["Distributions"," "," "," "," ",{"v":-180,"d":"(180)"},{"v":-120,"d":"(120)"}]
["Valuation adjustment"," "," "," "," "," ",{"v":-33,"d":"(33)"}]
["Conversion to mandatorily redeemable noncontrolling interest"," "," "," "," ",{"v":-974,"d":"(974)"}," "]
["Ending balance"," "," "," ",{"v":0,"d":"$ 0"},{"v":0,"d":"$ 0"},{"v":1120,"d":"$ 1,120"}]
["Common Stock"," "," "," "," "," "," "]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance, common stock (in shares)",{"v":9417332,"d":"9,417,332 "},{"v":9401057,"d":"9,401,057 "},{"v":9389953,"d":"9,389,953 "},{"v":9356421,"d":"9,356,421 "},{"v":9347220,"d":"9,347,220 "},{"v":9337125,"d":"9,337,125 "}]
["Beginning balance",{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":93,"d":"$ 93"},{"v":93,"d":"$ 93"}]
["Net issuance of common stock under stock incentive plans (in shares)",{"v":5637,"d":"5,637 "},{"v":16275,"d":"16,275 "},{"v":11104,"d":"11,104 "},{"v":24726,"d":"24,726 "},{"v":9201,"d":"9,201 "},{"v":10095,"d":"10,095 "}]
["Net issuance of common stock under stock incentive plans"," "," "," "," ",{"v":1,"d":"$ 1"}," "]
["Ending balance, common stock (in shares)",{"v":9422969,"d":"9,422,969 "},{"v":9417332,"d":"9,417,332 "},{"v":9401057,"d":"9,401,057 "},{"v":9381147,"d":"9,381,147 "},{"v":9356421,"d":"9,356,421 "},{"v":9347220,"d":"9,347,220 "}]
["Ending balance",{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":94,"d":"$ 94"},{"v":93,"d":"$ 93"}]
["Treasury stock"," "," "," "," "," "," "]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance",{"v":-348406,"d":"(348,406)"},{"v":-303897,"d":"(303,897)"},{"v":-274693,"d":"(274,693)"},{"v":-211646,"d":"(211,646)"},{"v":-164452,"d":"(164,452)"},{"v":-164452,"d":"(164,452)"}]
["Common stock repurchases",{"v":-42722,"d":"(42,722)"},{"v":-44509,"d":"(44,509)"},{"v":-29204,"d":"(29,204)"},{"v":-50426,"d":"(50,426)"},{"v":-47194,"d":"(47,194)"}," "]
["Ending balance",{"v":-391128,"d":"(391,128)"},{"v":-348406,"d":"(348,406)"},{"v":-303897,"d":"(303,897)"},{"v":-262072,"d":"(262,072)"},{"v":-211646,"d":"(211,646)"},{"v":-164452,"d":"(164,452)"}]
["Additional paid-in capital"," "," "," "," "," "," "]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance",{"v":284995,"d":"284,995 "},{"v":281062,"d":"281,062 "},{"v":281216,"d":"281,216 "},{"v":274204,"d":"274,204 "},{"v":272175,"d":"272,175 "},{"v":271950,"d":"271,950 "}]
["Net issuance of common stock under stock incentive plans",{"v":-168,"d":"(168)"},{"v":1220,"d":"1,220 "},{"v":-2348,"d":"(2,348)"},{"v":1934,"d":"1,934 "},{"v":478,"d":"478 "},{"v":-1213,"d":"(1,213)"}]
["Stock-based compensation",{"v":1746,"d":"1,746 "},{"v":2713,"d":"2,713 "},{"v":2194,"d":"2,194 "},{"v":1709,"d":"1,709 "},{"v":1551,"d":"1,551 "},{"v":1438,"d":"1,438 "}]
["Ending balance",{"v":286573,"d":"286,573 "},{"v":284995,"d":"284,995 "},{"v":281062,"d":"281,062 "},{"v":277847,"d":"277,847 "},{"v":274204,"d":"274,204 "},{"v":272175,"d":"272,175 "}]
["Retained earnings"," "," "," "," "," "," "]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance",{"v":1105371,"d":"1,105,371 "},{"v":1061556,"d":"1,061,556 "},{"v":1027127,"d":"1,027,127 "},{"v":957206,"d":"957,206 "},{"v":915667,"d":"915,667 "},{"v":869310,"d":"869,310 "}]
["Net income",{"v":56462,"d":"56,462 "},{"v":43815,"d":"43,815 "},{"v":34429,"d":"34,429 "},{"v":35987,"d":"35,987 "},{"v":41539,"d":"41,539 "},{"v":46357,"d":"46,357 "}]
["Ending balance",{"v":1161833,"d":"1,161,833 "},{"v":1105371,"d":"1,105,371 "},{"v":1061556,"d":"1,061,556 "},{"v":993193,"d":"993,193 "},{"v":957206,"d":"957,206 "},{"v":915667,"d":"915,667 "}]
["Accumulated other comprehensive (loss) income"," "," "," "," "," "," "]
["Increase (Decrease) in Stockholders' Equity [Roll Forward]"," "," "," "," "," "," "]
["Beginning balance",{"v":-77,"d":"(77)"},{"v":-275,"d":"(275)"},{"v":-333,"d":"(333)"},{"v":-603,"d":"(603)"},{"v":-657,"d":"(657)"},{"v":-615,"d":"(615)"}]
["Other comprehensive income (loss), net",{"v":-70,"d":"(70)"},{"v":198,"d":"198 "},{"v":58,"d":"58 "},{"v":241,"d":"241 "},{"v":54,"d":"54 "},{"v":-42,"d":"(42)"}]
["Ending balance",{"v":-147,"d":"$ (147)"},{"v":-77,"d":"$ (77)"},{"v":-275,"d":"$ (275)"},{"v":-362,"d":"$ (362)"},{"v":-603,"d":"$ (603)"},{"v":-657,"d":"$ (657)"}]

{"sheet":"Earnings Per Share (Details)","index":64,"n_rows":14,"n_cols":5,"rows_kept":14,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024","Dec. 30, 2023","Dec. 28, 2024","Dec. 30, 2023"]
["Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"," "," "," "," "]
["Net income attributable to Cavco common stockholders",{"v":56462,"d":"$ 56,462"},{"v":35987,"d":"$ 35,987"},{"v":134706,"d":"$ 134,706"},{"v":123883,"d":"$ 123,883"}]
["Weighted average shares outstanding"," "," "," "," "]
["Basic (in shares)",{"v":8096538,"d":"8,096,538 "},{"v":8358389,"d":"8,358,389 "},{"v":8203448,"d":"8,203,448 "},{"v":8561209,"d":"8,561,209 "}]
["Effect of dilutive securities (in shares)",{"v":90276,"d":"90,276 "},{"v":74082,"d":"74,082 "},{"v":88199,"d":"88,199 "},{"v":79079,"d":"79,079 "}]
["Diluted (in shares)",{"v":8186814,"d":"8,186,814 "},{"v":8432471,"d":"8,432,471 "},{"v":8291647,"d":"8,291,647 "},{"v":8640288,"d":"8,640,288 "}]
["Net income per share attributable to Cavco common stockholders"," "," "," "," "]
["Basic (in usd per share)",{"v":6.97,"d":"$ 6.97"},{"v":4.31,"d":"$ 4.31"},{"v":16.42,"d":"$ 16.42"},{"v":14.47,"d":"$ 14.47"}]
["Diluted (in usd per share)",{"v":6.9,"d":"$ 6.90"},{"v":4.27,"d":"$ 4.27"},{"v":16.25,"d":"$ 16.25"},{"v":14.34,"d":"$ 14.34"}]
["Stock Options"," "," "," "," "]
["Net income per share attributable to Cavco common stockholders"," "," "," "," "]
["Anti-dilutive common stock equivalents excluded (in shares)",{"v":0,"d":"0 "},{"v":0,"d":"0 "},{"v":169,"d":"169 "},{"v":316,"d":"316 "}]

{"sheet":"Fair Value Measurements - Sched","index":65,"n_rows":20,"n_cols":3,"rows_kept":20}
["Fair Value Measurements - Schedule of the Fair Value and Carrying Value of Financial Instruments (Details) - USD ($) $ in Thousands","Dec. 28, 2024","Mar. 30, 2024"]
["Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]"," "," "]
["Available-for-sale debt securities",{"v":21783,"d":"$ 21,783"},{"v":18669,"d":"$ 18,669"}]
["Marketable equity securities",{"v":7434,"d":"7,434 "},{"v":11961,"d":"11,961 "}]
["Book Value"," "," "]
["Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]"," "," "]
["Available-for-sale debt securities",{"v":21783,"d":"21,783 "},{"v":18669,"d":"18,669 "}]
["Marketable equity securities",{"v":7434,"d":"7,434 "},{"v":11961,"d":"11,961 "}]
["Non-marketable equity investments",{"v":5132,"d":"5,132 "},{"v":4956,"d":"4,956 "}]
["Consumer loans receivable",{"v":53636,"d":"53,636 "},{"v":44067,"d":"44,067 "}]
["Commercial loans receivable",{"v":94353,"d":"94,353 "},{"v":91041,"d":"91,041 "}]
["Other secured financing",{"v":-1622,"d":"(1,622)"},{"v":-1916,"d":"(1,916)"}]
["Estimated Fair Value"," "," "]
["Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]"," "," "]
["Available-for-sale debt securities",{"v":21783,"d":"21,783 "},{"v":18669,"d":"18,669 "}]
["Marketable equity securities",{"v":7434,"d":"7,434 "},{"v":11961,"d":"11,961 "}]
["Non-marketable equity investments",{"v":5132,"d":"5,132 "},{"v":4956,"d":"4,956 "}]
["Consumer loans receivable",{"v":57114,"d":"57,114 "},{"v":49105,"d":"49,105 "}]
["Commercial loans receivable",{"v":79664,"d":"79,664 "},{"v":80764,"d":"80,764 "}]
["Other secured financing",{"v":-1536,"d":"$ (1,536)"},{"v":-1841,"d":"$ (1,841)"}]

{"sheet":"Fair Value Measurements - Sch_2","index":66,"n_rows":8,"n_cols":3,"rows_kept":8}
["Fair Value Measurements - Schedule of Assumptions for Mortgage Servicing Rights (Details) $ in Thousands","Dec. 28, 2024 USD ($) loan","Mar. 30, 2024 USD ($) loan"]
["Fair Value Disclosures [Abstract]"," "," "]
["Number of loans serviced with MSRs | loan",{"v":3693,"d":"3,693 "},{"v":3842,"d":"3,842 "}]
["Weighted average servicing fee (basis points)",{"v":0.00348,"d":"0.348%"},{"v":0.003479,"d":"0.3479%"}]
["Capitalized servicing multiple",{"v":1.8629,"d":"186.29%"},{"v":1.8859,"d":"188.59%"}]
["Capitalized servicing rate (basis points)",{"v":0.006483,"d":"0.6483%"},{"v":0.006561,"d":"0.6561%"}]
["Serviced portfolio with MSRs (in thousands)",{"v":458268,"d":"$ 458,268"},{"v":482898,"d":"$ 482,898"}]
["MSRs (in thousands)",{"v":2971,"d":"$ 2,971"},{"v":3168,"d":"$ 3,168"}]

{"sheet":"Business Segment Information (D","index":67,"n_rows":17,"n_cols":6,"rows_kept":17,"merged":[[0,0,1,0],[0,1,0,2],[0,3,0,4]]}
["Business Segment Information (Details) $ in Thousands","3 Months Ended",null,"9 Months Ended"]
[null,"Dec. 28, 2024 USD ($)","Dec. 30, 2023 USD ($)","Dec. 28, 2024 USD ($) segment","Dec. 30, 2023 USD ($)","Mar. 30, 2024 USD ($)"]
["Business Segment Information"," "," "," "," "," "]
["Number of operating segments | segment"," "," ",{"v":2,"d":"2 "}," "," "]
["Net revenue",{"v":522040,"d":"$ 522,040"},{"v":446769,"d":"$ 446,769"},{"v":1507100,"d":"$ 1,507,100"},{"v":1374674,"d":"$ 1,374,674"}," "]
["Income before income taxes",{"v":69336,"d":"69,336 "},{"v":43907,"d":"43,907 "},{"v":168147,"d":"168,147 "},{"v":156245,"d":"156,245 "}," "]
["Total assets",{"v":1385767,"d":"1,385,767 "}," ",{"v":1385767,"d":"1,385,767 "}," ",{"v":1354160,"d":"$ 1,354,160"}]
["Factory-built housing"," "," "," "," "," "]
["Business Segment Information"," "," "," "," "," "]
["Net revenue",{"v":500860,"d":"500,860 "},{"v":426939,"d":"426,939 "},{"v":1445251,"d":"1,445,251 "},{"v":1318114,"d":"1,318,114 "}," "]
["Income before income taxes",{"v":63150,"d":"63,150 "},{"v":42070,"d":"42,070 "},{"v":168155,"d":"168,155 "},{"v":154121,"d":"154,121 "}," "]
["Total assets",{"v":1160795,"d":"1,160,795 "}," ",{"v":1160795,"d":"1,160,795 "}," ",{"v":1141237,"d":"1,141,237 "}]
["Financial services"," "," "," "," "," "]
["Business Segment Information"," "," "," "," "," "]
["Net revenue",{"v":21180,"d":"21,180 "},{"v":19830,"d":"19,830 "},{"v":61849,"d":"61,849 "},{"v":56560,"d":"56,560 "}," "]
["Income before income taxes",{"v":6186,"d":"6,186 "},{"v":1837,"d":"$ 1,837"},{"v":-8,"d":"(8)"},{"v":2124,"d":"$ 2,124"}," "]
["Total assets",{"v":224972,"d":"$ 224,972"}," ",{"v":224972,"d":"$ 224,972"}," ",{"v":212923,"d":"$ 212,923"}]